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“In theory there is no difference between theory and practice. In practice there is.”  
 
Yogi Berra, (1925 –2015)    
American professional baseball catcher, manager, and coach. 
  
  
  
ABSTRACT 
The nested case-control design is widely used in epidemiology for its efficiency, as it 
combines the advantages of both cohort and case-control designs. This design is an 
extension of the matched case-control design, where the matching variable is the time of 
occurrence of the outcome. Consequently, the nested case-control data are usually analysed 
with conditional logistic regression; however, this analysis suffers from various limitations.  
Several authors have developed novel statistical methods for alternative analyses of nested 
case-control data using basic information from the underlying cohort. Among these 
methods, one approach consists of ignoring the matching, weighting the sampled 
individuals to recover a representation of the underlying cohort and analysing the data by 
maximising a weighted partial likelihood. This method can be considered when two 
conditions are fulfilled: 1) the sampling was performed in a well-defined underlying cohort 
for which basic information is available, and 2) the exact sampling procedure is known. 
This thesis aimed to refine and extend the scope of the weighted likelihood approach in 
nested case-control data analysis by investigating the advantages of this method as an 
alternative to the traditional conditional logistic regression in several situations. The reuse 
of nested case-control data to address a research question regarding a new outcome, the 
calculation of absolute risk, the mitigation of the problem of overmatching, the 
maximisation of the data exploitation in case of clustered data and the analysis of 
subgroups of nested case-control data were addressed in this thesis. While Studies I and III 
were motivated by an actual epidemiological question for which data were available, 
simulation studies were the main approach used in Studies II and IV.  
Reusing nested case-control data to address a research question regarding another outcome 
was the central point of interest in Study I. Addressing an epidemiological question 
regarding the risk factors for contralateral breast cancer, for which data on contralateral 
breast cancer case patients were available, the feasibility of reusing nested case-control data 
from a previous study as the control dataset was studied. Practical aspects of the approach 
were highlighted, such as the consequences of reusing data which have narrow inclusion 
criteria, the restriction in the choice of the type of weights which can be calculated and the 
importance of having information on censoring dates for controls. In addition, we found 
that an imperfect reconstruction of the study base led to similar estimates in the analysis 
compared to an appropriate study base reconstruction; moreover, we confirmed that using 
unstratified weights (in cases of stratified sampling) provided similar exposure estimates 
than stratified weights, provided that adjustments were made on the confounder variables 
which drove the sampling. We also confirmed that using a naïve unweighted method 
instead of an appropriate method led to biased estimates. 
Absolute risk estimation was studied in Study II. Two methods were compared with both 
simulation studies and a real data application. The ability of each method to provide valid 
absolute risk estimates was investigated, in particular in cases of matched study designs. 
Both the Langholz-Borgan and weighted methods provided valid estimates in most 
situations, the latter showing slightly higher levels of precision than the former. In case of 
fine matching, the Langholz-Borgan method was more prone to be biased than the weighted 
method and had larger standard errors. 
In Study III, we handled nested case-control data, which had been collected to address an 
epidemiological question regarding how radiation therapy and smoking interact in their 
association with lung cancer in female breast cancer patients. Data on paired organs (breast 
and lungs) were collected for exposure and outcome variables, which provided clustered 
data at the individual level. The collected data was also characterised by the problem of 
overmatching which arose at the design stage. Using weighted partial likelihood allowed 
mitigation of the problem of overmatching and better exploited the collected data, 
compared to conditional logistic regression. In addition, a further advantage of the weighted 
approach was to enable calculating the absolute risk for a lung to develop cancer given the 
radiation therapy dose received for breast cancer treatment and the smoking habits of the 
patient. 
In Study IV, we compared the conditional logistic regression and weighted likelihood 
methods in terms of validity and efficiency of nested case-control data subgroup analyses, 
with subgroups defined by different variables measured at baseline. All investigated 
subgroup analyses provided valid estimates with both analyses. The advantages of weighted 
likelihood compared to conditional logistic regression were highlighted for the estimate’s 
precision. In addition, we showed that the weighting system enabled, on average, the 
reconstruction of the correct number of individuals at risk over time, for the whole cohort 
and in subgroups. 
In conclusion, the weighted likelihood approach showed several advantages compared to 
the traditional conditional logistic regression in nested case-control data analysis, which 
reinforces, refines and extends what has been previously shown in the literature. 
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1 INTRODUCTION 
Choosing the best observational study design in epidemiology is driven by both the 
research question and ethical and practical considerations, including the resources and time 
available for data collection. Two classical study designs are the cohort studies, the 
paradigmatic gold standard, and case-control studies, which have advantages in cost-
efficiency, and are preferred when the outcome under investigation is rare. To improve 
these study designs, alternative sampling methods have been suggested. This thesis 
examines one of them: the nested case-control design, which combines the benefit from the 
time aspect of cohort studies and the significant savings in cost and time of case-control 
studies.  
Conditional logistic regression is the traditional statistical approach used to analyse nested 
case-control data. This approach, however, has several limitations. For example, the data 
cannot be reused to address a new research question regarding another outcome, or to 
estimate the absolute risk of developing the outcome of interest. Since the late 1990s, 
alternative statistical methods have been developed to analyse nested case-control data. 
These non-traditional methods ignore the matching between cases and controls, and use 
limited information from the underlying cohort.  
Among these methods, the Inverse Probability Weighting (IPW) method consists of 
weighting the individuals and analysing the data by maximising a weighted partial 
likelihood. The weights are the inverse of the probability for each individual to be sampled 
into the nested case-control study and aim to reconstruct the number of individuals at risk in 
the full cohort. Simulation studies have validated the IPW method and have consistently 
shown that it provides more precise exposure estimates, compared to the conditional 
logistic regression method. Although the method has long been available, it is still largely 
ignored by medical researchers and is uncommonly used by biostatisticians and 
epidemiologists. 
The main goal of this thesis is to refine and extend the scope of this weighted partial 
likelihood method and make it more accessible to the research community by providing 
guidelines illustrated with applications to clinical datasets. The contribution of this study 
may encourage a shifting of the standard of statistical analysis of nested case-control 
studies from conditional logistic regression to the more powerful and versatile weighted 
partial likelihood method. 
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2 BACKGROUND 
2.1 Cohort and case-control studies 
In epidemiology, for ethical and practical reasons, observational studies are far more often 
conducted than randomised control trials. The most popular observational designs have long 
been and still are cohort and case-control study designs, with the former considered as the 
gold standard when randomisation is not possible.1,2  
A cohort is a well-defined group of study individuals who are followed from inclusion in the 
study until the time of occurrence of an event of interest (i.e. outcome) or censoring. Some 
cohort members will be exposed to the risk (or protective) factor under investigation, while 
other will remain unexposed. How exposure is related to time until outcome is analysed by 
contrasting the unexposed subjects with the exposed subjects. In contrast, the classical case-
control design consists of sampling a subset from a larger population, which can be a cohort. 
Individuals experiencing the outcome, i.e. cases, and controls, who do not experience the 
event, are sampled separately. Usually all cases are selected, and controls randomly sampled 
among the non-cases. The sampling of controls can be a simple random sampling, but more 
often involves stratification (i.e. matching). How the outcome is related to the exposure is 
analysed by contrasting the case and control individuals. 
Beyond the difference in the way the participants of the study are selected, the cohort design 
enables the modelling of the time aspect of the occurrence of an outcome, while the case-
control study design is far more cost-effective but usually does not take the time into 
account.1,2  
2.2 Time-to-event analysis of cohort studies 
2.2.1 Basic concepts 
To set up a cohort of individuals who are followed over time requires a precise definition of 
the outcome/event of interest, a precise definition of the start and the end of follow-up time 
period, a relevant choice for the time scale and precise inclusion/exclusion criteria for the 
individuals who enter the cohort. Subjects who do not experience the event during follow-up 
are censored. The censoring time is usually either end of follow-up, or the time when the 
individual was lost to follow-up for other reasons (such as death, emigration or withdrawal 
from the study). The observed follow-up time is the minimum between censoring time and 
event time. Moreover, the individuals are not always followed from time zero, but can 
sometimes be observed from some later time. This often happens, for example, when age is 
used as time scale. When individuals enter the cohort after time zero is referred to as delayed 
entry.  
The time-to-event or survival time T is the central variable in cohort analysis and the 
probability density function f(t) describes how the variable T is distributed. This function is 
used to further express the distribution function of T:  
 4 
 F(t) = P(T < t) = ∫ 𝑓(𝑢)𝑑𝑢
𝑡
0
  (2.1) 
which in turn is related to one of the central functions of interest in survival analysis: the 
survivor function  
 S(t) = 1 - F(t) (2.2) 
which expresses the probability to have survived until time t.  
Another central function in survival analysis is the hazard function h(t) which expresses the 
risk of experiencing the event of interest at time t, provided one has survived until that time. 
The two central functions h(t) and S(t) are related to each other by means of the cumulative 
hazard function 
 H(t) = ∫ ℎ(𝑢)𝑑𝑢
𝑡
0
  (2.3) 
The relationship between these central concepts are derived with simple algebra 3:  
 H(t) = –log S(t) (2.4) 
The cohort design is illustrated in Figure 2.1. The members of this small cohort enter the 
study from the beginning (i.e. no delayed entry) and are followed over time.  
 
 
 
 
 
 
 
 
 
Figure 2.1: Cohort of 15 individuals with ordered event and censoring times. 
2.2.2 Modelling survival data with Cox proportional hazards model 
The most usual way to describe the hazard function for an individual i at time t, is to express 
this hazard as a product of two functions: a baseline hazard (h0(t)), which is multiplied by 
another function which includes the variables which characterise individual i. In the Cox 
proportional hazards model, this expression is  
 hi (t|Xi, Zi, β, γ) = h0(t) exp(β´Xi + γ’Zi) (2.5) 
  5 
where Xi and Zi are the vectors of covariate(s) and confounder(s) for individual i, and β and γ 
are the vectors of the corresponding coefficients. The baseline hazard function h0(t) can vary 
over time but this function does not need to be specified in the Cox proportional hazards 
model, which is the reason why this model is referred to as a semi-parametric model. As the 
ratio of the hazard function of two individuals does not include the baseline hazard (which is 
cancelled out in the ratio), the hazard ratio is constant over time: a feature which gives its 
name to the model, i.e. the proportional hazards model.  
Ordering the event times ti, the vectors of coefficients β and γ are estimated by maximising 
the following partial likelihood 4:  
 
  (2.6) 
 
where Ri is the group of individuals who are still at risk just before time ti and is called the 
risk set at time ti.  
2.2.3 Comments on the risk set concept 
The central concept in the Cox regression analysis is the concept of risk set. The data which 
is used in each contribution of the product (2.6) is represented in Figure 2.2. The figure 
highlights the concept of risk set as well as related features. 
 
 
 
 
 
 
 
 
Figure 2.2: Cohort of 15 individuals with ordered event and censoring times and the risk set Ri at each 
event time. 
 In a Cox regression the only interest lies in the number of individuals who are present 
in the risk sets at the exact event times, disregarding what could have happened just 
before or after;  
 The ranking of the time is only used to identify who is in the risk sets, but even this 
ranking is not formally used in Equation 2.6;  
𝐿(𝛽, 𝛾) = ∏
exp[𝛽′𝑋𝑖 +  𝛾′𝑍𝑘)]
∑ exp[𝛽′𝑋𝑘 +  𝛾′𝑍𝑘)]𝑘𝜖𝑅𝑖𝑡
𝑖
           
 6 
 For case i, the number of terms in the denominator of Equation 2.6 is as large as the 
number of individuals in the risk set Ri, decreasing thus with time.   
 
This last feature may give some clue to a possible sampling strategy within the risk sets, 
which could reduce the volume of data to be collected and used for analysis.  
2.3 Case-control studies and logistic regression analysis 
2.3.1 Basic concepts 
When the outcome of interest is rare, the cohort is not the most efficient way to address an 
etiologic question as it will require collecting data on a high number of individuals over a 
long period of time in order to obtain a sufficient number of cases. When an exposure is 
expensive to collect (as with biomarkers), collecting data for all of the individuals in a cohort 
is very costly. In these two situations, the case-control design would be much more efficient.   
In addition to defining the outcome/event of interest with precision, the sampling procedure 
of the control individuals requires careful consideration in order to enable valid inference. 
Cases and controls have to be representative of one single population (i.e. the study base) but 
are not required to be sampled within a cohort. Indeed, most of them are not, but are rather 
sampled within a dynamic underlying population in which the members may vary over 
time.5,6 
In contrast to the cohort design, time (to event) is not the main area of focus in the case-
control design. Time is however considered in the sampling: the source population is 
followed over a particular period of time and, in addition, the sampling of the controls can be 
chosen to be performed at different time points. It can be performed at the beginning of the 
study period, concurrently (by matching on time with the cases), at the end of the study 
period, or during the entire study period.6-8 When the sampling is done within a cohort (the 
situation of interest in this thesis), the three first choices are respectively referred to as 
inclusive sampling, incidence density sampling and exclusive sampling.6,7 
2.3.2 Modelling and analysing case-control data 
Case-control data are usually described using a logistic model, and analysed using logistic 
regression. Confounding is adjusted for by including the confounders as covariates in the 
regression model. Such analyses provide odds ratios which measure the association between 
the case/control status and the exposure. The odds ratio estimates either a risk ratio, a rate 
ratio or an odds ratio, depending on the sampling design used for selecting controls and the 
source population (cohort or dynamic).7 
Case-control studies have long been, and still are, criticized as being less reliable than studies 
utilising a cohort approach, despite numerous developments and scientific papers 
demonstrating the strong links between the two designs as well as similarities of the 
parameters which are estimated from both designs.6-7,9-11 
  7 
2.3.3 Individually matched case-control studies  
Matching on factors which are possible confounders is commonly used in case-control 
studies. The purpose of matching is to improve efficiency by achieving a better balance in the 
number of cases and controls in the confounder strata. On the other hand, as the cases and 
controls are (artificially) made more similar for both the matching factor and the exposure, 
the process of matching introduces a bias which has to be controlled for in the analysis.12 
When individual matching is performed on Z, matched sets are obtained in which one case is 
associated with m controls and the individuals in a set share the same value of the matching 
variable Z. Such data is analysed by conditional logistic regression characterised by the 
following likelihood 13:  
 
   (2.7) 
 
where Si is the set including case i and the m matched controls. The form of this likelihood is 
reminiscent of the partial likelihood (2.6) used for analysing cohort data, but γ is not 
estimated in the likelihood as the confounder Z is used as matching factor. The link between 
the analysis of cohort data and the analysis of matched case-control data can be highlighted 
with the likelihoods 2.6 and 2.7. Each contribution in both likelihoods includes one single 
‘set’ (an entire risk set Ri for the cohort; a matched risk set Si for the matched case-control). 
Time is not formally included in any of the analyses. 
2.4 Nested case-control design and its traditional analysis 
Optimising the efficiency of epidemiological research is a continuous challenge, leading to 
the development of new designs and new statistical methods to analyze the collected data. 
The nested case-control design was proposed by Thomas in 1977 14 and aims to combine the 
benefit from the time aspect of the cohort design and the significant savings in cost and time 
of the case-control design.2,15-17 
2.4.1 Basic concept 
Within a well-defined cohort, the nested case-control design includes all cases but only a 
random sample of controls: at each failure time among all individuals who are at risk at that 
time, a defined number m of controls is randomly sampled. This incidence density sampling 
is also called ‘risk-set sampling’ as indeed, the sampling is performed within each risk set as 
illustrated in Figure 2.3.2,6,17  
 
 
𝐿(β) = ∏
exp[𝛽′𝑋𝑖]
∑ exp[𝛽′𝑋𝑘]𝑘𝜖𝑆𝑖𝑖
        
 8 
 
 
 
 
 
 
 
 
Figure 2.3: Risk set sampling of nested case-control data with a single control per case (m=1) in a 
cohort of 15 individuals.  
2.4.2 Different ways to consider the nested case-control design 
The nested case-control design is an extension of the case-control design, in particular the 
individually matched case-control design, where the matching variable is the time of 
occurrence of the outcome. Hence, statistical methods developed to analyse matched case-
control data can be used.  
As the sampling is performed within the risk sets, it emphasises the link between the nested 
case-control and the cohort designs. Instead of including the whole risk set at each event time, 
only a few individuals are included. As for the cohort design, the same individuals can 
participate in several sampled risk sets (since individuals are randomly sampled, they can be 
sampled several times), and controls included in a sampled risk set can later become cases 
during their follow-up. These two features are typical of cohort design. 
As the design associates aspects of both cohort and case-control designs, it is interesting to 
see that some authors 1,6-8 present this as an extension of case-control design and others 15,17,18 
as a cohort sampling method. These two points of view emphasise once more the links 
between cohort and case-control designs, which are still too often presented as two radically 
different approaches when performing epidemiological research. This observation was made 
by Miettinen in 1982 9 and is still valid today. 
2.4.3 Nested case-control design in epidemiological research 
Nested case-control design is regularly used in epidemiology but a simple literature search on 
PubMed shows that this design is still far less used than cohort and case-control designs. 
There are, however, numerous published cohort studies which might have been more cost and 
time efficient if they had sampled a nested case-control study within their cohort.  
On the other hand, it seems that the concept of nested case-control sampling is poorly 
understood in the research community: in a PubMed search with the only search criterion 
  9 
‘nested case-control[Title]’, at least three hits among the first 10 were misusing the term 
‘nested case-control’.19-21 When a study claims to use a nested case-control design, it 
regularly means that the case-control study was sampled within a cohort without using the 
risk set sampling strategy.19-22 Unfortunately, such confusion does not help to promote the 
correct use of the design.    
2.4.4 Traditional statistical analysis: the conditional logistic regression 
Nested case-control data, considered as a sample within the cohort, can be described in the 
proportional hazards framework. Using the proportional hazards model (Equation 2.5) to 
express the association between the time-to-event and the covariates, the classical approach 
for estimating β and γ with nested case-control data is to maximise a partial likelihood similar 
to (2.6) where the sampled risk sets R’i are used instead of the complete risk sets Ri, or, 
similar to (2.7) where R’i are the matched risk sets 14: 
 
  (2.8) 
 
where R’i is the sampled risk set for case i. If, in addition to time, the nested case-control 
sampling included the confounder(s) as matching factor(s), the likelihood (2.8) will not 
include the vector γ as in the likelihood (2.7). In practice, this is handled in statistical software 
by either using a conditional logistic regression or a Cox regression stratified on the sets 
which include the case and its sampled controls.  
To ensure valid inference, the nested case-control design requires that the incomplete data 
arising from the subsampling of the cohort must be missing at random. This means not only 
that controls have been randomly selected within the strata defined by the matching variables 
but also that, conditional on the complete covariates, any missing exposure information does 
not depend on the unobserved value.17,18,23 If the condition of ‘missing at random’ is fulfilled, 
the analysis will provide cost-efficient unbiased estimates of hazard ratios for measured risk 
factors under the proportional hazards model.2  
As the nested case-control data analysis is performed with fewer data, a loss in power is 
expected. Defining the relative efficiency as the ratio of the variance of the parameter 
estimated from the full cohort to the variance estimated from the nested case-control design, 
it has been shown that, in the case of one covariate, this ratio follows the m/(m+1) rule under 
the null hypothesis, with m the number of controls in a matched set. If only one control is 
sampled for each case, the relative efficiency is ½, implying that the variance obtained with 
the nested case-control design is twice as large as the one obtained from the cohort.17 When 
the regression coefficients depart from zero (i.e. under the alternative hypothesis), or when 
multiple covariates are included in the model, this rule does not strictly apply any more and 
efficiency can be either reduced 17 or increased.24  
𝐿(β, 𝛾) = ∏
exp [𝛽′𝑋𝑖 + 𝛾
′𝑍𝑖]
∑ exp [𝛽′𝑋𝑘 +  𝛾′𝑍𝑘]𝑘𝜖𝑅´𝑖𝑡
𝑖
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2.4.5 Limitations of the nested case-control design and its analysis 
While conditional logistic regression provides unbiased results and is easily conducted for a 
nested case-control study, the matching on time of cases and controls implies that: 
• the analysis is valid for this particular time scale; 
• the controls cannot be readily reused to address another outcome; 
• the design is not optimal for estimating absolute quantities such as baseline hazard 
and absolute risk; 
• analysis of data collected on paired organs (e.g., eyes, lungs, breasts) has to be 
restricted to reduced data. 
These limitations have long been regarded as weaknesses of the nested case-control 
design,2,16,17,25 but have also stimulated the development of other statistical approaches. In 
addition to these limitations, which are mainly related to the use of conditional logistic 
regression, other issues arise from the sampling strategy and would be avoided with a cohort 
design. These issues include the problem of overmatching at the design stage and the use of 
post-hoc subgroup analyses.  
As the work presented in this thesis was motivated by the need to overcome these limitations 
and issues, they are described in more detail in the next section. 
2.4.6 Limitations and issues in nested case-control studies 
2.4.6.1 Re-using nested case-control data 
2.4.6.1.1 Motivation 
Large and well-defined cohorts are regularly used to address research questions: 
national/regional health and population registers (Swedish Registers 26) are used to select 
cases for a specified outcome and subsequently sample relevant controls using sampling 
methods (risk sets or others), before collecting more expensive data such as those retrieved by 
review of medical charts or administering questionnaires. There is an interest in reusing these 
valuable data to answer other research questions. In other types of large cohorts including 
biobank initiatives (UK Biobank,27 Life Gene 28), large amount of data, often expensive to 
gather (especially molecular and genetic information), are stored. There is now an increasing 
interest in utilising these data efficiently as well as for several purposes. 
When data are not reused, researchers miss the opportunity to make more efficient use of 
their data resources. For example, a study in which a series of nested case-control studies 
were designed to address several research questions in the same underlying cohort,29,30 would 
have been more cost- and time- efficient if collecting less control data and reusing the data to 
address the different research questions. 
On the other hand, when previously collected data are reused to address new research 
questions, they are often analysed with naïve statistical methods.31,32 Lin et al. 33 showed that 
case-control association studies often misuse statistical methods when utilising data to 
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analyse secondary phenotypes. In nested case-control studies, as in any regular matched case-
control study, the control data is a biased subset of the population and cannot be readily 
reused to address a new research question. Special attention is needed in order to correct for 
the sampling bias. Yung and Lin 34 showed in case-control studies that naïve methods, 
including the following, can lead to severe bias: analysis of the combined sample of cases and 
controls ignoring the case-control ascertainment, or adjusted for the case-control status as an 
additional variable, as well as the case-only or control-only analyses.  
2.4.6.1.2 Weighting the observations to reuse case-control data 
As the cases are overrepresented compared to the non-cases, any case-control sample is 
biased by definition. Depending on the strategy used to sample the controls, the control data 
in an unmatched design, may or may not be a biased sample of the population, while the 
sample of controls in a matched design will be biased. As the nested case-control sample is 
matched design on time, the same consequence applies.  
Reusing (matched) case-control data is feasible provided the sampling bias is corrected for. 
Reilly et al.35 addressed such reuse of case-control data using a weighted approach. From the 
survey literature, it is known that using the sampling probabilities which lead to the available 
data is the key to compensating for biased sampling schemes.36,37 Reilly et al 35 showed how 
control or case-control data can be reused to address a new research question by weighting 
the individuals by the inverse of their sampling probabilities and, therefore, making them 
representative of the study population.35 This inverse probability weighting (IPW) approach 
can easily be conducted with a straightforward weighted analysis implemented with any 
standard statistical software.  
2.4.6.1.3 Line of thought 
In the approach of Reilly et al.,35 as the case and control observations were essentially 
reweighted to construct an unbiased cross-sectional representation of the population, the 
results apply to cross-sectional data only, and not to nested case-control studies. However, the 
simplicity of the IPW approach is appealing and inspired the same 38 and other authors 39 to 
develop such an approach for nested case-control data. 
2.4.6.2 Absolute risk estimation  
2.4.6.2.1 Motivation  
Risk prediction is currently used by practitioners and public health authorities to make 
decisions on medical treatments, patient follow-up and healthcare regulations. Risk prediction 
models are usually constructed from data collected in cohort studies such as the famous 
Framingham Heart study of cardiovascular risk factors.40-43 
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2.4.6.2.2 The Breslow estimator in cohort studies 
When using a cohort design and analysing the data in the framework of the Cox model, the 
Breslow estimator is the key estimator which allows calculating the cumulative baseline 
hazard H0, and hence calculating absolute risk 
3,44: 
 (3.1) 
 
 
Using H0(t) obtained above together with an estimate of the vectors β and γ and the equations 
2.2 and 2.4, the absolute risk (Fi) for an individual i to develop the outcome at time t is given 
by  
 Fi(t) = 1 - exp (−𝐻0(𝑡) exp[𝛽′𝑋𝑖 + 𝛾′𝑍𝑖  ]) (3.2) 
where Xi and Zi are the vector of the individual’s covariates. 
2.4.6.2.3 Adapted Breslow estimator for nested case-control data 
As cases are over-represented in nested case-control data, the Breslow estimator can not be 
readily used to estimate the cumulative baseline hazard H0(t).  
Langholz and Borgan 45 proposed a method to estimate absolute risk from nested case-control 
data and developed an estimator for the cumulative hazard in the context of the proportional 
hazards model. Their estimator of the cumulative baseline hazard is similar to the Breslow 
estimator with an additional time-dependent weight w(ti) in the denominator:   
 
 
  (3.3) 
 
with R’i the sampled risk set at time ti, w(ti) a time dependent weight which is the inverse of 
the sampling fraction in the cohort’s risk set Ri: w(ti) = Ri/(m+1), and 𝛽 and γ the estimated 
coefficients in the traditional conditional logistic regression analysis. 
Despite the availability of the Langholz-Borgan 45 method developed almost two decades 
ago, few epidemiological nested case-control studies have used their estimator.46 Studies 
which have used population-based nested case-control data to construct their absolute risk 
model are nevertheless not uncommon 47-49; however, the nested case-control data in these 
studies provided the estimates for the risk factors (i.e. the vectors β and γ) while absolute 
measures were derived by combining the risk estimates with incidence rates from population 
register data.  
The Langholz-Borgan 45 approach uses basic information from the cohort to supplement the 
nested case-control data. The denominator contribution of the estimator is upweighted, 
correcting for the over-representation of cases in the nested case-control data set. However, in 
𝐻0(t) = ∑
𝐼 (𝑡𝑖 ≤ 𝑡)  
∑ exp[𝛽′𝑋𝑖 + 𝛾′𝑍𝑘] 𝑤(𝑡𝑖)𝑘∈𝑅´𝑖
 
𝑖
     
𝐻0(𝑡) = ∑
𝐼 (𝑡𝑖 ≤ 𝑡)  
∑ exp[𝛽′𝑋𝑘 +  𝛾′𝑍𝑘]𝑘∈𝑅 𝑖
 
𝑖
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case of additional matching (on another variable than time), it remains unclear how the 
Langholz-Borgan method can be accommodated, as it uses conditional logistic regression to 
estimate the regression coefficients. In such a matched situation, it will not be possible to 
estimate the coefficients γ of the matching factors. The authors argued that the method could 
easily be extended to nested case-control sampling involving matching factors, but they did 
not explain it in detail. Ganna et al. 50 used this method and showed that it did not give 
reasonable estimates when the nested case-control sampling involved matching factors other 
than time. 
2.4.6.2.4 Line of thought 
If part of the limitation in estimating absolute risk with nested case-control data is overcome 
with the Langholz-Borgan estimator, the use of conditional logistic regression remains an 
obstacle to achieving reliable estimates for the matching variables and hence an absolute risk 
estimate for matched design. How this estimator can be accommodated in case of matching is 
worth addressing.  
2.4.6.3 Clustered data  
2.4.6.3.1 Motivation 
When the research question concerns paired organs (e.g., lungs, breasts, eyes) for each of 
which exposure and outcome measurements are available, the statistical analysis has to take 
care of the clustering. This can be addressed with a cohort design by using a frailty model 
approach, which is an extension of the Cox model.51 In this approach, the survival model 
includes both fixed and random effect terms, where the fixed effect term comprises the 
observed portion of the model and the random effect term, or frailty term, accounts for the 
unexplained heterogeneity in the model: in other words, it accounts for the correlation within 
the clusters. 
For nested case-control designs, however, the clustered data cannot readily be handled by 
conditional logistic regression, as there are two levels of clustering: the set which comprises 
(at least) two individuals (case and control(s)) and then the individual who has a pair of 
organs. Facing such situation, researchers usually solve the problem by using the cases and 
their ipsilateral control 52 or adopt a case-only design 53 in which the healthy organ in the pair 
is used as the control for the unhealthy one.  
2.4.6.3.2 Breaking the matching in (usual) case-control studies 
As the issue of this double level of clustering arises due to the matching of cases and controls, 
tackling the question of how/if it is possible to perform valid unconditional analysis with 
matched data is worth considering. 
Performing valid analysis of matched data requires the matching variables to be considered in 
the analysis, but does not strictly require matched analysis (such as conditional logistic 
regression).12 This implies that ignoring (or ‘breaking’) the matching can be considered, i.e. 
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ignoring the formal link between the case and the matched controls in the analysis. When the 
matching is ignored, valid analysis must include the factors which were used for the matched 
sampling as additional variables in the unconditional logistic regression model.12,54 Using 
such an approach can lead to more efficient analysis than the matched analysis, for example, 
when sets are suffering from missing data 12,55; however, the method works well if the 
matching factor included in the model does not have too many strata (i.e. fine matching), 
otherwise the unconditional logistic regression would lead to biased results.56 
2.4.6.3.3 Line of thought 
If this could be an approach for the usual case-control studies, the situation, however, seems 
more complicated for nested case-control data: the number of strata is the same as the number 
of cases and will lead to the problem of numerous strata mentioned above. However, the fact 
that breaking the matching will remove the clustering at the set level and would allow the 
information gathered for the two organs to be used will retain interest in this approach. 
2.4.6.4 Overmatching 
2.4.6.4.1 Matching versus overmatching 
When the distributions of the potential confounders are substantially different in cases and 
controls, the matching aims to balance cases and controls within the strata defined by 
confounders and, in this way, to improve the efficiency of the stratified analysis.1,12,54,57 
However, if the cases and the controls are matched on a variable which is correlated to the 
risk factor under study, and this risk factor is not an independent risk factor or part of the 
causal mechanism, the problem known as ‘overmatching’ can be encountered. In such a 
situation, the efficiency of the analysis can be much reduced due to cases and controls being 
too similar for their exposure and many sets not contributing in the stratified analysis.1,54,58-60  
2.4.6.4.2 Mitigating overmatching 
It has been argued that for case-control studies suffering from overmatching, pooling the data 
in several strata will improve the efficiency.58 The gain from this approach will be more 
important if the odds ratio is expected to be large and also depends on the exposure 
prevalence among the controls.58  
2.4.6.4.3 Line of thought 
To my knowledge, this topic has never been addressed in studies using the nested case-
control design. However, it can be hypothesised that breaking the matching in nested case-
control data could provide some advantages when overmatching is present as it would also 
benefit from making use of all individuals included in the study.  
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2.4.6.5 Subgroup analyses  
2.4.6.5.1 Motivation 
While a research study is designed to answer a specific research question, it is common for 
investigators to conduct subsequent analyses of subgroups in order to investigate associations 
in more detail. Some recent examples for the nested case-control design are the studies 
conducted by Devore et al.,61 Kim et al., 62 Boursi et al. 63 and Liu et al.64 
There is an abundant literature on subgroup analyses for randomised clinical trials.65-70 The 
general advice, however, is to restrict subgroup analyses as much as possible, as the main 
issue is their overuse and over interpretation, in addition to the underuse of appropriate 
statistical tests for interaction. 
There is little doubt that the situation is similar with observational studies. While this study is 
in line with the advice given above and does not wish to promote an excessive use of 
subgroup analyses, the main objective was to investigate whether such subgroup analyses are 
valid per se when they are performed with nested case-control data.   
The subgroups can be defined by the outcome (for example, when studying breast cancer, a 
subgroup could be defined by the histology of the breast cancer (e.g., ductal breast cancer, 
lobular breast cancer), or the TNM stage (e.g., breast cancer with TNM stage <4)), and by a 
covariate which could be an independent risk factor, a confounder or an effect modifier (for 
example, in studying menopaused women, or BRCA1/2 carriers, or smokers, etc.).  
In cohort studies, defining a subgroup by the outcome is equivalent to addressing a new 
research question in the same cohort. Defining a subgroup by a covariate is not a problem 
either, as it involves a redefinition of the inclusion/exclusion criteria. In nested case-control 
studies, since the sampling of the participants is related to the outcome of interest (and 
perhaps also to matching variables), the data at hand is not a representative sample of the 
population of interest. A subgroup selected from this sample will also be a non-representative 
sample of the sub-population of interest and, therefore, could generate invalid estimates.  
Likewise, defining a nested case-control subgroup by the outcome is also equivalent to 
addressing a new research question. This should not raise any problems: any set where the 
case does not correspond to the new definition will be removed, reducing the data at hand to 
answer the new question (unless the removed subjects are reused, which can be an option). 
Defining a nested case-control subgroup by a covariate which was used for the sampling (i.e. 
which was a matching factor) should not raise any problems either, as the sampling was 
stratified on the variable defining the subgroup. But if the covariate used to define the 
subgroup was not a matching factor, it is unclear to what extent such sub-group analyses 
could be valid. 
 16 
2.4.6.5.2 Line of thought 
To the best of my knowledge the validity of subgroup analyses of nested case-control data 
has not been addressed. Moreover, the main concern facing such subgroup analysis was that 
it is not known who is being analysed and who these analysed individuals represent. 
A second concern is about the efficiency of the analyses. Should subgroup analysis be valid 
with nested case-control data, it is clear that conditional logistic regression will be inefficient: 
the definition of a subgroup will restrict the analysis to sets that, by chance, have a case and at 
least one control in the defined subgroup. The number of sets which will be excluded from 
the analysis will depend on the prevalence of the subgroup but also on how this variable 
correlates with all others, including the outcome.  
Once again, an analysis that ignores the matching and allows using all individuals belonging 
to the defined subgroup should have advantages over the conditional logistic regression.  
2.4.6.6 In conclusion 
Two main ideas guided the search for potential solutions for the mentioned limitations: 
breaking/ignoring the matching, which enables using more data because cases and controls 
are no longer tied in sets, and weighting the individuals, which permits the recovery of the 
study population.  
In this thesis, a weighted partial likelihood method was used, which resulted from statistical 
developments inspired by these ideas. The method, also called Inverse Probability Weighting 
(IPW) method, started to be developed in the 1990s and is presented in the Methods section 
(Chapter 5). 
 
 
 
 
  17 
3 AIMS 
The overall aim of the thesis was to refine and extend the scope of the weighted partial 
likelihood method in nested case-control data analysis by investigating the advantages of 
the method as an alternative to the traditional conditional logistic regression. We addressed 
the following themes: reusing data (Studies I, III and IV), estimating absolute risk (Studies 
II and III), solving a problem of overmatching at the design stage (Study III), analysing 
clustered data (Study III) and analysing subgroups (Study IV). 
The specific methodological and statistical aims included: 
1. To appropriately reuse nested case-control data to investigate a new outcome within 
the same underlying cohort (Study I).  
 
2. Compare two methods of estimating absolute risk with nested case-control data, and 
investigate the ability of each method to provide valid estimates for matched study 
designs (Study II).  
 
3. Investigate the advantages of weighted partial likelihood methods compared to 
conditional logistic regression for analysing overmatched and clustered nested case-
control data (Study III).  
 
4. Compare conditional logistic regression and weighted partial likelihood methods in 
terms of validity and efficiency of subgroup analyses of nested case-control data 
(Study IV).  
 
Two of these studies (Studies I and III) were motivated by epidemiological questions for 
which the collected data gave the opportunity to address additional 
methodological/statistical questions. The choice was made to focus on these latter 
questions. 
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4 MATERIALS AND CONTEXT OF THE STUDIES 
The methodological work in Studies I and III was motivated by epidemiological research 
questions for which data were available, and for which both the epidemiological questions 
and the methodological/statistical questions were of interest. In this section, it is proposed to 
present the epidemiological context, questions and data for these two studies.  
Studies II and IV were simulations studies. To simulate the data in Study II, realistic values 
were used for generating the cohort from which nested case-control studies were further 
sampled. These values came from an epidemiological study and the description of the data is 
part of this section. In addition to the simulation data, a real cohort was used to illustrate how 
the results applied in a real setting, both in Studies II and IV. The cohort used for this purpose 
is also presented in this section. 
4.1 Collected real-world data  
4.1.1 The CBC study (Study I) 
4.1.1.1 Investigating risk factors for contralateral breast cancer 
Contralateral breast cancer (CBC) is defined as a second primary breast cancer in the 
contralateral side, detected at least three months after the first breast malignancy.71,72 Of all 
women with breast cancer, approximately 10 to 15% will develop an invasive contralateral 
breast cancer during the 20 years after initial diagnosis.72 Risk factors for contralateral breast 
cancer have been investigated and studies have identified that ‘family history’ (i.e. up to third 
degree relatives who had a breast cancer),73-76 a ‘non-ductal histological type’ of the initial 
breast cancer 71,77 and a young age at diagnosis of the initial breast cancer 76,78,79 are 
associated with an increased risk of developing contralateral breast cancer, while parity is 
often reported as a non-significant protective factor.73,80,81 Multifocality of the initial breast 
cancer tumour has, to our knowledge, never been investigated. Since multifocality is reported 
to be associated with the higher-risk lobular histological type,82,83 it could be a factor of 
interest to investigate. The epidemiological question which Study I aimed to answer was: Is 
multifocality of the initial breast cancer tumour a risk factor for contralateral breast cancer, 
and is parity confirmed as a protective factor for contralateral breast cancer? 
4.1.1.2 The available data  
4.1.1.2.1 Case data: contralateral breast cancer cases  
Eight hundred and fifty three (853) patient cases of contralateral breast cancer, diagnosed 
between 1976 and 2005, were identified in the Stockholm-Gotland Cancer Register, which 
includes all patients diagnosed with cancer in this region since 1976. Patients’ medical charts 
were collected in order to retrieve additional variables of interest: known risk factors (‘family 
history’, ‘histological type’ and age at diagnosis date), potential confounders (chemo- and 
hormonal therapy) and the two potential risk factors to be investigated (multifocality of the 
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breast tumour and parity).72 All cases had their contralateral breast cancer three months or 
more after their first breast cancer and cases who had any other malignancy (except breast 
cancer) at any time before the contralateral breast cancer diagnosis date were excluded. 
4.1.1.2.2 Potential control data: the ‘Metastases study’ 
As data was collected for case patients within a well-defined cohort, the first idea about how 
to answer the epidemiological question was to collect controls in a nested case-control 
design, but it would be time and cost demanding.  
It was thus suggested to reuse control data from another nested case-control study. A good 
candidate for that purpose was the ‘Metastases study’ which was a nested case-control study 
which also collected data for breast cancer patients registered in the Stockholm-Gotland 
Cancer Register. In this study, cases (191) were breast cancer patients who had metastases 
subsequent to breast cancer and controls (615) were sampled in a nested case-control design 
and remained free of metastases until their date of sampling. The same variables as for the 
contralateral breast cancer cases were retrieved from the medical charts as well as dates of 
diagnoses (including breast cancer, contralateral breast cancer and metastases). However, 
several additional inclusion/exclusion criteria had been used in the ‘Metastases study’: 
patients had to be younger than 76 years old at breast cancer diagnosis, had their breast 
cancer diagnosis in the restricted calendar period of 1997-2005 and had to be treated for their 
breast cancer with chemo- or hormonal therapy. An additional complexity was that the nested 
case-control sampling in this study was stratified on three factors: intended treatment (chemo-
, hormonal therapy, or a combination of these), age category (<45, 45-54, >54 years), and 
period of breast cancer treatment (1997-2000 or 2001-2005).  
Reusing this data set as the control data set for the contralateral breast cancer cases requires 
some attention, as the control data are a biased control sample. On the one hand, there is an 
overrepresentation of patients with metastasis, and on the other hand, as control patients were 
matched on time and on three other variables to the metastases cases, they cannot be readily 
reused to address a research question about a new outcome. The solution chosen was to have 
an IPW approach. 
4.1.1.2.3 The underlying cohort 
The condition enabling the use of these data sets to answer the epidemiological question 
using an IPW approach is to retrieve the correct study base, i.e. the underlying cohort from 
which the study patients (both cases and controls) were sampled. The different inclusion 
criteria for the two data sets described above, as well as the use of matching variables in the 
nested case-control sampling of the ‘Metastases study’, render the data situation complex. 
However as patients from both studies were included in the same register, and as dates of 
events (any malignancy and death) were available for all patients, both in the register data and 
in the two data sets, it was possible to align these data sets in order to use a weighted 
approach.  
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The data set retrieved from the Stockholm Breast Cancer Register comprised 32,153 breast 
cancer patients from 1976 to 2008 who were followed up for any other malignancy. The date 
of the patient’s death, if this happened, was also available. This data set included patients 
with wider inclusion criteria than the two other data sets, which made it a worthy candidate to 
reconstruct an appropriate study base for the aligned set of case and control patients. An 
important part of the work, was to reconstruct a coherent study base in parallel to align and 
assemble the cases and controls data sets. This is represented in Figure 4.1. 
 
Figure 4.1: Alignment of the three data sets. As the inclusion criteria were different, they are called A 
(for the contralateral breast cancer cases), B (for the ‘Metastases study’) and C for the underlying 
cohort. 
 
4.1.2 The SAMBAL study (Study III) 
4.1.2.1 Investigating radiation therapy as a risk factor for subsequent lung cancer in 
female breast cancer patients 
The effect of radiation therapy as a potential risk factor for subsequent cancer diagnosis has 
been investigated in several studies.84,85 For women who have had postoperative breast cancer 
radiation treatment, an increased risk of lung cancer has been shown for at least 5 years, even 
decades in some cases, after the adjuvant treatment.85,86 However, the main risk factor for 
developing lung cancer is smoking, and the risk of developing lung cancer after radiotherapy 
was shown to be particularly increased among smokers.53,85,87 How these two carcinogens 
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interact with each other is not fully understood, and the aim of the SAMBAL (i.e. molecular 
epidemiology of secondary lung cancer) study was to address the question: How does 
radiotherapy after breast cancer interact with smoking regarding the risk for lung cancer? 
4.1.2.2 The nested case-control data 
To address this question, participants were selected using a nested case-control design within 
the Swedish Cancer Register which includes all patients diagnosed with cancer in Sweden 
since 1958.88 Cases were breast cancer patients, diagnosed between 1958 and the end of 2001 
and subsequently diagnosed with lung cancer. Incidence density sampling was used to select 
matched controls (1 control per case) from breast cancer patients without any subsequent 
cancer diagnosis before their date of selection.  
Seven hundred thirty (730) lung cancer cases and 726 controls were included in the study 
sample. As 5 years is estimated as a reasonable latency period for observing a radiation-
induced solid tumour,85,89,90 analysis was restricted to cases whose lung cancer occurred at 
least 5 years after the breast cancer diagnosis and their matched controls. Analysis was also 
restricted to patients who had information available on radiation therapy for breast cancer 
treatment, which led to a data set with 538 cases and 513 controls. 
The data included the radiation dose received at each lung as well as the laterality of the 
breast and lung cancers, which means that each patient had a pair of dose measurements. In 
each of the case-control pairs of this nested case-control design, two levels of clustering were 
thus identified which will be of interest in the methodological approach of the present study.  
In addition, the data were suspected to be overmatched as cases and controls were matched 
on decade of the breast cancer diagnosis and the treatment and radiation therapy protocols are 
strongly associated with time. The breast cancer patients entered the cohort from 1958 and at 
that time and until the mid-seventies, 80% of the patients received radiation therapy. As a 
consequence, patients in a matched set were more likely to share the same radiation therapy 
exposure, which in turn makes the set unused in any conditional analysis.   
4.2 Study data in simulations studies 
4.2.1 Simulation coefficients value in Study II 
In the simulation settings in Study II, data was generated from a proportional hazards model 
using realistic values for the baseline hazard and the covariates regression coefficients. The 
chosen values of the variables were mimicking the observed values of a nested case-control 
study of coronary heart disease conducted within the Singapore Chinese Health Study.91 The 
variance-covariance matrix and the means of the observed variables were used to first 
generate a multivariate normal distribution for gender, age, cholesterol, High-Density 
Lipoprotein (HDL), Systolic Blood Pressure (SBP), smoking status and antihypertensive 
treatment status, that were further rounded to the nearest integer (age), or dichotomised 
(gender, smoking status and antihypertensive treatment status). The correlation coefficients 
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between the variables, together with the variables’ mean value and variance are presented in 
Table 4.1. 
Table 4.1: Variables means and variance-correlation matrix of Singapore Chinese Health Study 
nested case-control data 
 Age 
(years) 
Gender Cholesterol 
(mg/dL) 
HDLa 
(mg/dL) 
SBPb 
(mm Hg) 
Treatment  
statusc 
Smoking  
status 
mean 63.1 0.51 203 53.8 136 0.27 0.18 
Variance-correlation matrix 
Age  59.3 -0.158 0.049 0.148 0.267 0.130 -0.056 
Gender   0.229 -0.201 -0.315 0.002 -0.001 0.273 
Chol    1278 0.362 0.103 -0.096 -0.026 
HDL    159 -0.054 -0.158 -0.130 
SBP     488 0.187 0.039 
Treatment      0.218 -0.128 
Smoking status       0.190 
a HDL: High-Density Lipoprotein;  
b SBP: Systolic Blood Pressure;   
c Treatment status: antihypertensive treatment status. 
4.2.2 Data for illustration in Studies II and IV 
In Studies II and IV, in addition to the simulation studies, how the methods work was 
illustrated in a real situation. In both studies, a real cohort of 75,856 brothers, sisters and 
children of all non-Hodgkin’s lymphoma patients (probands) registered in the Swedish 
Cancer Register from 1958 to 2007 was used. In this cohort, the family members were 
followed on the age time-scale, from birth until emigration, death, or the end of the study (31 
December 2007), whichever occurred first. The included variables were: gender of the family 
member, gender of the patient, type of relationship between the family member and the 
patient (sibling or child) and year of birth of the family member. The cohort was described 
and otherwise studied in detail by Lee et al.92  
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5 METHODS 
The issues and limitations presented in the background section (Chapter 2) can be divided 
into two groups: issues due to the sampling design which would not arise within a cohort 
design (overmatching and subgroup analyses) and limitations due to the use of conditional 
logistic regression for analysing nested case-control data (reusing data, absolute risk 
estimation and analysis of clustered data).  
To overcome the limitations of the conditional logistic regression in nested case-control data 
analysis, researchers have been developing novel statistical methods since the nineties. Their 
approaches can differ significantly, but a common point is that the matching between the 
cases and their controls is broken so that the controls are no longer tied to their matched 
case.18,23,39,93-95 
Once the matching between cases and controls is broken, several authors have considered a 
weighted approach for the analysis in which the individuals are upweighted by their sampling 
probability.23,39,93 This appealing approach, which originally comes from the survey literature, 
36,37 and is also applied to case-control design 35 is used in this thesis as presented in this 
chapter. 
5.1 Study base reconstruction and weighted partial likelihood  
5.1.1 Study base reconstruction 
The main idea when individuals from a sample are upweighted is to recover the study base, 
i.e. the underlying study population. Compared to the situation of Reilly et al. 35 with regular 
(matched) case-control studies, the particularity of the study base in a nested case-control 
study is the time aspect because the aim is to recover the cohort with the correct pattern of 
time at risk for the entire follow-up. This is illustrated in Figure 5.1, where Figure 2.3 is re-
organised to present the nested case-control sample on the upper part of the graph and the 
remaining non-sampled individuals of the cohort on the lower part. In order to recover a valid 
representation of the study base by using the nested case-control data (in the dashed frame), 
only the non-cases need to be weighted as all cases from the cohort are usually part of the 
nested case-control sample. 
Another question which needs to be answered before proceeding further is: Which study base 
needs to be reconstructed? Indeed, as presented in the former chapter, one may deal with two 
data sets which must be combined but have been sampled from two overlapping cohorts 
rather than from the same one. The challenge then is first to identify the correct study base 
which needs to be reconstructed. 
A third aspect to be considered is the availability of information on the whole study base. As 
the idea is to up-weight individuals with the inverse of their sampling probabilities, 
information is needed on the exact sampling procedure, and on the study base from which the 
sampling was performed. This means that a well-defined cohort is needed for which basic 
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information should be available, i.e. all relevant dates and variables used for the sampling. 
Once the study base has been identified and basic information is available, sampling 
probabilities and weights can be calculated. 
 
 
 
 
 
 
 
 
Figure 5.1: The nested case-control sample (in the dashed frame) versus the non-sampled individuals 
from the cohort in the lower part of the graph. 
 
5.1.2 Kaplan-Meier weights 
Samuelsen 39 suggested calculating the probability for an individual to be sampled in the 
nested case-control data with an expression which mimics the risk set sampling strategy. In a 
nested case-control design, all cases are usually included in the data, so that their sampling 
probability and hence their weight is equal to one. In contrast, the probability for an 
individual to be sampled as a control increases with the duration of his/her follow-up time 
and with the number of sampled controls at each event time, and decreases for an increasing 
number of individuals at risk at each event time (i.e. the size of the risk set Ri, which is itself 
evolving with time).  
At each event time ti, an individual k with starting time Sk (Sk ≤ ti ) and censoring or event 
time Tk (Tk ≥ ti) is available to be sampled. Assuming mi controls were sampled for case i 
from a risk set of Ri individuals, the probability pki that k is sampled at time ti for case i is 
given by mi/(Ri - 1). Multiplying the probabilities of not being sampled (1 - pki) during the 
entire follow-up (i.e. between Sk and Tk), and subtracting this product from one, gives the 
probability pk for individual k to be sampled at least once during his/her follow-up time. In 
short 39:  
 (5.1) 
 
 
where Yk(ti) is an indicator of the case-control status of individual k at time ti.  
𝑝𝑘 =  1 − ∏ [1 −
𝑚𝑖
𝑅𝑖 − 1
 ]
𝑖, 𝑆𝑘 ≤𝑡𝑖≤𝑇𝑘
 [1 −  𝑌𝑘(𝑡𝑖)]  
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The weight wk is the inverse of this probability. The weights aim to ‘reconstruct’ the number 
of individuals at risk in the full cohort, idea which is similar to that which is done in survey 
inference.37 
In our small cohort in Figure 5.1, applying Equation 5.1, the weights are 6.7 for individual 5, 
and 2.5 for individuals 11 and 14. All other individuals are cases and get a weight of 1. 
Exploring how these weights reconstruct the pattern of time at risk in the cohort gives the 
following results: At time t1, where 15 individuals were included in the risk set, Samuelsen 
weights recover 16 (15.7, rounded) individuals, and at time t2, t3 and t4, the weights recover 
15, 7 and 6 individuals for numbers that were actually 13, 9 and 6, respectively. It can be 
noted that this weighting system appears to be effective, even with such a small cohort. 
On a practical level, the weights can be calculated by using simple readily available software 
commands: a Kaplan-Meier analysis of the cohort provides the number of individuals in the 
risk sets at each event time. From these numbers, with simple algebra only including 
subtraction, division and cumulative products, the probabilities and thus the weights are 
computed. As the Kaplan-Meier analysis is the central tool used for calculating these weights, 
this name is usually given to the weights developed by Samuelsen.96,97 
5.1.2.1 Stratified Kaplan-Meier weights  
In case of stratified sampling, i.e. sampling involving additional matching on a confounder Z, 
the expression 5.1 can be generalized 38,98: 
 (5.2) 
 
where Ri
Z is the number of individuals at risk at ti who have the same value for the 
confounder as the case and I(zk = zi) is the indicator that case i and individual k have the same 
value for the confounder Z.  
Regarding the implication in the computing aspect, the only difference is that Equation 5.1 
has to be applied in each of the strata defined by the matching factor. However, in cases of 
fine matching, the Kaplan-Meier weights could fail to provide a correct representation of the 
cohort, as high sampling probabilities could lead to weights which are too light.97 
5.1.3 glm/gam weights 
Another type of weights which is also easy to implement was proposed by Kim and De 
Gruttola.93 The weights are obtained by modelling the sampling probability of the controls 
with a parametric model (such as logistic regression (glm) or generalised additive models 
(gam)) which includes the available covariates which drove the sampling and the time span 
during which the individual was available for sampling. The model is run on the whole cohort 
from which the cases are excluded. As the time is included in the model, the increasing 
probability of selection with time at risk is accommodated by the model. These weights are 
referred to as the glm/gam weights.96,97,99  
𝑝𝑘 =  1 −  ∏ [1 −
𝑚𝑖
𝑅
𝑖
𝑍
 − 1
 𝐼(𝑧𝑘 = 𝑧𝑖)]  [1 −  𝑌𝑘(𝑡𝑖)]𝑖, 𝑆𝑘 ≤𝑡𝑖≤𝑇𝑘   
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The calculation of the glm/gam weights requires all cohort members to have a variable which 
indicates whether they have been sampled for the nested case-control study. In contrast, the 
Kaplan–Meier type of weights does not need this sampling indicator to calculate the risk set 
sizes involved in the weights calculation. This is an advantage when working with data which 
were anonymised to ensure individuals’ data protection after the sampling has been 
performed within the study base. Another feature of the glm/gam weights is that they require 
some modelling which is not needed with the Kaplan-Meier method. 
5.1.4 Weighted partial likelihood statistical method 
Analysing weighted data in order to obtain the coefficients estimate β is done by maximising 
a weighted partial likelihood (pseudo-likelihood) whose expression is 39:  
 
 (5.3) 
 
where R*i is the collection of all cases and sampled controls at risk at time ti, and wk is the 
weight for individual k. Any individual in the pooled data is a subject who is followed from 
starting time until the outcome or censoring date. Figure 5.2 represents risk sets R*i which 
include all individuals who are pooled together, weighted and followed up.  
 
 
 
 
 
 
 
 
Figure 5.2: Pooled individuals of the nested case-control sample and risk sets Ri*. The data are re-
organised as in Figure 5.1. The three sampled controls represent the non-cases in the whole cohort and 
are weighted. 
In practice, the analysis is performed in statistical software by using a weighted Cox 
regression with the pooled data and unique individuals who are characterised by a time-to-
event or time-to-censoring, as in the (usual) Cox analysis of an entire cohort.100 Samuelsen 
derived an asymptotic variance for β that accounts for the Kaplan-Meier weights, 39 and Kim, 
101,102 using the same weights proposed an approximate jackknife standard error. However, 
using a robust variance estimator is usually considered as a reasonable choice for the 
weighted analysis.96,97 
𝐿(β, γ) = ∏
exp [𝛽′𝑋𝑖 + 𝛾
′𝑍𝑖 ]
∑ exp[𝛽′𝑋𝑘 +  𝛾′𝑍𝑘] . 𝑤𝑘𝑘𝜖𝑅∗𝑖𝑡
𝑖
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In this approach, as all cases and sampled controls are pooled together, an initial benefit 
appears: while each contribution in the likelihood (2.8) only included the case and the mi 
sampled controls, the likelihood (5.1) uses all cases and sampled controls who are still at risk. 
By using more individuals in each contribution of the likelihood, a gain in statistical power is 
expected compared to the conditional logistic regression analysis.  
5.1.5 Achievements with the weighted approach 
5.1.5.1 Hazard ratio estimates 
The way in which the weighted method performs in data analyses has been studied through 
simulation studies.18,93,96,97,99-103 Whatever the type of weights used, the weighted method 
provides valid estimates of the hazard ratio β with a slightly better precision than the 
conditional logistic regression analysis. Comparing the use of Kaplan-Meier and glm/gam 
weights, they give comparable estimates and show similar empirical variances,96,97,99 but 
when censoring time is linearly correlated with a covariate, the glm/gam weights method is 
slightly more efficient than the Kaplan-Meier method,99 and in case of fine matching, the 
glm/gam weights perform better than the Kaplan-Meier weights.97 
5.1.5.1.1 Hazard ratio estimates in case of stratification 
Considering the expression 2.5 (i.e. hi (t|Xi, Zi, β, γ) = h0(t) exp(β´Xi + γ’Zi,)), an important 
achievement of the weighted method is the ability to estimate regression coefficients for 
covariates which were matching factors, i.e. it enables estimating the γ’s. 
As the matching is broken, the estimation of the regression coefficients are no longer 
performed within the risk sets R’i as in the conditional logistic regression but on pooled data, 
i.e. the risk sets R*i. As the cohort is reconstructed thanks to the weights, the γ’s can be 
estimated in the same way as can be done in a cohort analysis, provided the weights have 
been correctly calculated using the stratified expression 5.2.   
If estimating the β’s while analysing a stratified nested case-control sample is the only area of 
interest, Støer et al.97 showed that the accuracy of the estimates of the exposure’s hazard ratio 
was similar for unstratified weights (Equation 5.1) and stratified weights (Equation 5.2) 
provided one adjusted in the analysis for the confounder(s) which were used as matching 
variable(s). If this unexpected result could be demonstrated to be true in general, it would 
represent a useful simplification when using the method and would also mean that, in the case 
of fine matching, the reconstruction of fine strata is unnecessary, avoiding a problem which 
arises with these weights, as mentioned above.97  
5.1.5.2 Absolute risk estimation with weighted partial likelihood 
The ability to validly estimate both β’s and γ’s gives the opportunity to revisit the Breslow 
estimator and develop an expression which exploits the weighted approach. It seems that this 
idea was being investigated in 2012, as just previous to the approach outlined in Study II, Cai 
et al. 104 developed an estimator for prognostic accuracy of biomarkers from nested case-
 30 
control data using the weighted approach of Samuelsen to estimate the coefficients of the risk 
factors (𝛽) and adapting the Breslow estimator to the weighted situation. The adapted 
cumulative baseline hazard Breslow estimator is:  
 
  (5.4) 
 
with R*i, the collection of all cases and sampled controls at risk at time ti, and wk the weight 
of control k, as in the likelihood (5.3). This development provides a new way to consider 
absolute risk estimation with nested case-control data.  
5.2 Other likelihood approaches 
In parallel with the approaches using a weighted partial likelihood, other methods have been 
developed. Scheike and Juul 94 and Saarela et al. 18,103 suggested a complete cohort likelihood 
approach in which the cohort sampling design is treated as a missing data problem, and which 
requires modelling of the distribution of the partially observed covariates. Another approach 
was explored by Keogh and White 95 in which multiple imputation techniques using the fully 
observed data to fit the imputation models are used, addressing thus the nested case control 
data analysis as a missing data problem as well. All these methods have been investigated and 
compared in several studies, and all of them present advantages and disadvantages.18,96,103,105  
The approaches just mentioned above, as well as the weighted approach, require data to be 
available on basic information regarding time-to-event(s) or censoring for all participants of a 
well-defined cohort. In cases of stratified sampling the cohort should also contain information 
on the matching variables for all of its members. The full likelihood and multiple imputation 
methods will benefit from having access to more information in the cohort, should this 
information be available.105 Other variables than the times to event(s) or censoring and 
matching variables which would be available in the full cohort are not used to compute the 
weights in the weighted approach (with Kaplan-Meier weights), but can be used to improve 
the imputation model or the model that describes the covariates distribution in the full 
likelihood method. As both methods also require some modelling, they are vulnerable to 
model misspecification and they also require more programming.18,96,103 In addition, these 
approaches need an indicator telling which individuals were sampled and which were not, 
among all cohort’s members, an information which is not always available. 
Last but not least, as the nested case-control design is sometimes chosen in order to reduce 
the computing burden, when for example, mega data-bases involving large cohorts with 
multiple time-varying exposures or covariates are handled 106, the methods involving full 
likelihood or multiple imputation would definitely show some drawback in such cases. 
𝐻0(𝑡) = ∑
𝐼 (𝑡𝑖 ≤ 𝑡)  
∑ exp[𝛽′𝑋𝑘 +  𝛾′𝑍𝑘] 𝑤𝑘𝑘∈𝑅∗𝑖
 
𝑖
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5.3 Simulation methods 
Simulating is an effective tool to explore a hypothesis or asses the performance of statistical 
methods in relation to the known truth. Simulation methods were the main tool used in 
Studies II and IV. Following the guidelines outlined by Burton et al.,107 the simulation 
settings were decided according to the aims of the simulation. Cohorts were simulated whose 
estimates served as reference for all subsequent analyses of the nested case-control data 
which were further sampled in these cohorts and analysed with various methods (i.e. we 
adopted what Burton et al, called ‘moderately independent simulations’ 107). For the different 
scenarios (i.e. different types of cohorts), however, fully independent simulated data were 
generated.  
5.3.1 Generating the data set 
In order to generate the data set, the use of realistic scenarios was aimed for reflecting 
plausible epidemiological situations; however, settings were also challenged with more 
extreme (unrealistic) values.   
5.3.1.1 Time-to-event 
The distribution of the time-to-event was generated using the method described by Bender et 
al. and Crowther et al. 108,109: 
Simulating time-to-event starts from Equation (3.2) i.e. F(t) = 1- exp (-H0(t) exp (β’X + γ’Z)). 
As the values taken by this distribution are included in the interval [0, 1], as well as the values 
taken by (1 – F), simulated values can be generated from a uniform distribution (U [0, 1]). 
Using U = exp (-H0(T) exp (β’X + γ’Z)), (with T the time-to-event variable), time-to-event 
values can be generated, provided H0 can be inverted: T = H0
-1[-log(U) exp(-β’x) ].108,109 
When T cannot be solved analytically, iterative root finding methods are used. 
5.3.1.2 X’s and Z’s distribution 
In Study II, the data used were generated from the covariates mean and the variance-
covariance matrix retrieved from a study of coronary heart disease nested in the Singapore 
Chinese Health Study.91 The correlation structure between the variables from one scenario to 
another was not modified.   
In contrast, in Study IV, data were generated from normal and binomial distributions, using 
mean values which were retrieved or inspired by the epidemiological data analysed in Study 
III, but in the different scenarios explored, some variation was made in the way the Z 
variables were correlated to the exposure variable. This way of generating data gave a huge 
freedom to simulate variables which were defined according to their role relative to the 
exposure. Beside the exposure, variables were generated which were either independent risk 
factors, confounders or effect modifiers. Table 5.1 describes the variables used in the main 
simulation scenario of Study IV. 
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5.3.1.3 Vectors of coefficients β and γ 
The same differences between Studies II and IV apply for the vector of coefficients β and γ. 
In study II, the values were retrieved from the same, already mentioned, study of coronary 
heart disease. In some scenarios though, these values were modified. In Study IV, the 
coefficients were inspired by the epidemiological data of Study III, but different values were 
explored for the β’s and γ’s in the scenarios which were considered. The chosen values for 
the β’s and γ’s in our main scenario are presented in Table 5.1. 
5.3.1.4 Baseline hazard 
In Study II, the baseline hazard which best described the time-to-event distribution in the 
study of coronary heart disease was found to be a Weibull distribution and this was used in 
the final setting. In Study IV, a constant baseline hazard was used in the main setting (Table 
5.1) and a Weibull baseline hazard in additional settings. 
Table 5.1: Variables distribution and parameters’ value in the main simulation setting of Study IV 
Variable Distribution  Coefficient Hazard ratio 
Exposure Xe Binomial (N, p*) βe = 0.405 1.5 
Independent risk factor Xirf Normal (μ = 0, σ = 10) βirf = 0.020 1.02 
Confounder Xc Binomial (N, 0.5) βc = 0.953 2.6 
Effect modifier Xem Binomial (N, 0.3) βem = 1.386 4 
Interaction coefficient between Xe and Xem: βinteract βinteract = 0.69 2 
*p is defined by the association between Xe and Xc: P(Xe | Xc) = exp(
log(4)+log(1/4)∗Xc
    1+exp(log(4)+log(1/4)∗Xc
) 
Baseline hazard Constant h0 = 0.0005  
 
5.3.1.5 Censoring time 
In both Studies II and IV, the censoring time was generated with an exponential function, and 
a maximum follow-up period length was also included. In addition, in some of the explored 
scenarios in Study IV, censoring distribution was made depending on the effect modifier. 
5.3.2 Sampling of nested case-control studies in the simulated cohorts 
Once the cohort data were set up, nested case-control sampling was simulated in Studies II 
and IV. For each scenario, 500 cohorts of N individuals (N varying between 50,000 and 
100,000) were simulated, and in each of them, one nested case-control study was sampled 
before various analyses were performed on the nested case-control sample and the cohort. 
The nested case-control sampling involved the choice of the number of controls per case, and 
the choice of whether or not to perform a stratified sampling. Different scenarios 
corresponded to different choices. The number of controls per case was either two or five, 
and the sampling did not involve matching for several scenarios, while for other scenarios, 
matching was performed on one or two confounders. Fine matching was also performed. 
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5.3.3 Assessment of the performance of the statistical methods  
In both studies, the performance of the statistical methods used to analyse the nested case-
control data set in comparison to the estimates obtained from the cohort was assessed. The 
bias and the accuracy of the estimates were evaluated. 
5.4 Statistical software  
All simulation studies and analyses of the generated data and the real data sets were 
performed in R. Codes used in Study II were developed by Salim and collaborators. Unique 
codes were developed to generate the data in Study IV. To perform the nested case-control 
sampling within the created cohort, codes were used which had already been developed 
within the team. Unique codes were also created to calculate the Kaplan-Meier weights which 
form the central part of the weighted partial likelihood method presented above. Part of this 
development is available at: http://www.meb.ki.se/~biostat/. These pieces of codes show how 
a cohort can be generated, and a nested case-control study be further sampled, how weights 
can be calculated, and how they can be assigned to the controls. The R packages which are 
needed to calculate the Kaplan-Meier weights are the survival and plyr packages. 
Støer et al. developed the multipleNCC package, implemented in R and available on CRAN 
since autumn 2014.110,111 This package fits Cox proportional hazard models with a weighted 
partial likelihood, including different types of weights (among which the Kaplan-Meier and 
glm/gam weights), and accommodates the reuse of controls for several endpoints. However, 
the package requires all data to be in a single data set, which is not always possible in real 
research situations, such as in Studies I and III.  
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6 OVERVIEW OF THE FOUR STUDIES  
(RATIONALE AND OBJECTIVES) 
Each of the issues presented in Chapter 2 was tackled in the thesis. Reusing nested case-
control data to address a research question regarding another outcome (first issue) was the 
central point of interest in Study I. However, as breaking the matching (which was done in all 
four studies) is similar to reusing cases and controls 39, the theme ‘reusing the data’ was 
somehow explored in all studies.  
The absolute risk estimation (second issue) was studied in detail in Study II with simulation 
studies, and performed in Study III on a real-world data set. Breaking the matching to 
overcome problems due to overmatching (third issue) and clustering (fourth issue) was 
addressed in Study III, and subgroup analyses (fifth issue) were investigated in Study IV by 
means of simulation studies.  
In this latter still unpublished study, we also investigated in detail how well the Kaplan-Meier 
weights were able to reconstruct the number of individuals at risk over time in the cohort and 
in subgroups. Study IV shed new light on the results which were previously obtained in the 
first three studies. 
As previously stated, in Studies I and III, we worked with real data sets, to investigate 
epidemiological questions, in addition to the methodological/statistical questions which were 
the main interest. Studies II and IV were mainly simulations studies where the real data set 
analysis served as illustration.  
This chapter aims to present the rationale and the specific objectives of each study. As several 
research questions were addressed in several studies, Table 6.1, at the end of this chapter, 
summarises questions and studies in which they were explored. 
6.1 Study I: Reusing nested case-control data to address a 
research question regarding a new outcome  
6.1.1 Why a methodological question was addressed in Study I 
While Study I was motivated by the epidemiological question regarding the risk factors for 
contralateral breast cancer, we focused our interest on the methodological and statistical 
questions. The reason lies below.  
All published studies using the IPW approach to reuse nested case-control data aimed to 
validate the method and used various approaches to compare the estimates.38,96,97,100,112 The 
authors had either access to the full cohort from which the nested case-control was sampled 
(simulation studies), 96,97,100 or controls sampled for the new outcome which could be used in 
the validation step.38,100,112 The advantages of the method were demonstrated in these ideal 
illustrative data analyses. All reported an increased efficiency of the nested case-control 
design when additional controls are used which were previously sampled to study another 
 36 
outcome in the same underlying cohort. However, the method has been largely ignored by 
medical researchers and has not found its way into routine use by biostatisticians and 
epidemiologists.29,101 To the best of my knowledge, there is no published work of an 
application of the method to a setting where the data have features typical of real research 
situation, such as cases and available controls being sampled from different, but overlapping, 
cohorts and with different inclusion and sampling criteria.  
In this application, beyond the work of Salim et al. 38,100 and Støer et al. 96,97,112 we wanted to 
assess the advantages and limitations of reusing nested case-control data in a real situation 
where the second study did not gather any controls, so that the only option would be to reuse 
prior control data. We wanted also to clarify the conclusion of Støer and Samuelsen 96,97 
concerning the choice of weights, highlighting how the feasibility of calculating several types 
of weights may depend on the data at hand. 
6.1.2 The methodological questions  
To assess the advantages and limitations of reusing nested case-control data in a real and 
complex situation includes assessing different items which are listed below:  
 What is the impact of using an appropriate method rather than a naïve statistical 
analysis when reusing nested case-control data? 
 Is there a difference in the estimates when reusing a whole nested case-control data set 
or when only the sampled controls of this data set are reused? 
 What is the impact of the accuracy of the reconstruction of the underlying cohort from 
which the weights are calculated? 
 What is the impact of using unstratified weights instead of stratified weights to estimate 
covariates coefficients in a matched design? 
 What is the impact of the choice of data which are reused to analyse the new outcome 
(when a choice is possible) on the final data set and for the interpretation of the 
estimates? 
 What is the impact of using selection dates of the controls when the censoring date in 
the nested case-control data set is ignored? 
 Is there a practical advantage to using Kaplan-Meier or glm/gam weights? 
6.2 Study II: Estimating absolute risk with nested case-control 
data 
6.2.1 Why Study II was performed 
Langholz and Borgan 45 developed an estimator for the cumulative baseline hazard (Chapter 
2). However, it remained unclear how to accommodate the approach to estimate absolute risk 
with nested case-control data in case of stratified sampling, because the conditional logistic 
regression which is used to retrieve the estimates will not be able to estimate the coefficients 
for the matching factors, while they are needed in the absolute risk estimation.50 
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The weighted method developed by Cai et al. 104 (Chapter 4) for estimating absolute risk with 
nested case-control data was used by Zhou et al. 113 who analysed data collected in a nested 
case-control design to estimate the absolute risk of developing rheumatoid arthritis. Although 
they reported results obtained with the weighted method, the article did not provide details on 
how they implemented the method.  
While both the Langholz-Borgan and the weighted methods are not new, the implementation 
of these methods using standard statistical software is still lacking, as well as a complete 
comparison of the absolute risk estimations with the two methods, especially in case of 
stratification.  
6.2.2 Research questions  
The study thus aimed to compare the two methods for estimating absolute risk from nested 
case-control data, in both simulations studies and real-world data, to examine their 
performance and discuss the relative merits of each. Specifically, the questions which the 
study aimed to answer were: 
 Are these methods suitable to estimate absolute risk from matched nested case-control 
data?  
 Are the Langholz-Borgan and weighted methods comparable in terms of accuracy and 
efficiency? 
6.3 Study III: Advantages of weighted partial likelihood over 
conditional logistic regression in analysing clustered and 
overmatched nested case-control data 
6.3.1 Why a methodological question was addressed in Study III 
While addressing an epidemiological question regarding how smoking and radiation therapy 
interact in the risk of developing lung cancer in female breast cancer patients, we however 
focused our interest on the methodological and statistical aspects. The reason lies below.  
The collected data included information on paired organs: radiation doses assessment for both 
lungs and laterality of the cancers (breast and lung). The data were gathered in a nested case-
control design which was also overmatched, due to the matching on breast cancer decade of 
diagnosis (Chapter 4). The overmatching and clustering of the data rendered the weighted 
partial likelihood approach attractive compared to conditional logistic regression analysis. 
Furthermore, as the sample was performed within the Swedish Cancer Register, the weighted 
partial likelihood method could be used. 
As overmatching problems result in losing matched sets in the analysis (the sets where case 
and controls share the same exposure value), breaking the matching was thought to be a 
potential solution worth exploring. The idea was inspired by Samuelsen 99 who suggested 
pooling nested case-control data to reduce the efficiency loss due to missing covariates 
(another unrelated topic but with some similar consequences to overmatching) and by 
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Brookmeyer 58 who, for case-control studies, showed that pooling the data from several strata 
could help solving or mitigating a problem due to overmatching.  
Regarding the clustering feature, the weighted approach will allow reducing the two levels of 
clustering (set and individual levels) to a single level (individual level) and when using robust 
standard error in the analysis, the clustering at the individual level will be accounted for. 
In addition to mitigating this problem of overmatching and handling the paired data, the 
weighted partial likelihood will enable the estimation of cumulative risk studied in detail in 
Study II, which was considered a further advantage.  
The specific statistical question which the study aimed to answer was: 
 What are the advantages of using weighted Cox regression compared to conditional 
logistic regression in analysing overmatched and clustered nested case-control data? 
6.4 Study IV: Analysing subgroups with nested case-control data 
6.4.1 Why Study IV was performed 
As subgroup analyses are regularly performed in nested case-control studies 61-64 and as it 
remains unclear if these analyses can provide valid estimates, simulation studies were 
performed, which aimed to answer the following specific questions: 
 Are subgroups analyses with nested case-control data valid when a subgroup is 
defined by a covariate measured at baseline? 
 Is one method to be preferred among weighted likelihood method and conditional 
logistic regression for subgroup analyses of nested case-control data? 
 How well does the weighting system reconstruct the cohort and each subgroup? 
 How well does the weighted likelihood method with unstratified weights in 
recovering the exposure coefficient in each subgroup in case of matched design? 
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Table 6.1: Specific methodological research questions and studies where these were addressed. 
Theme, context and questions: Addressed in 
Reusing data: Breaking the matching to address a research question regarding a new outcome 
Question 1 
Question 2 
 
Question 3 
What is the impact of the accuracy of the reconstruction of the underlying cohort from which the weights are calculated? 
Is there a difference in the estimates when reusing a whole nested case-control data set or when only the sampled controls of this 
data set are reused? 
What is the impact of the choice of data which are reused to analyse the new outcome (when a choice is possible) on the final data 
set and for the interpretation of the estimates? 
Study I 
Study I 
 
Study I 
Breaking the matching and weighting individuals  
Question 4 
Question 5 
 
Question 6 
Question 7 
Question 8 
How well does the weighting system reconstruct the cohort and each subgroup of the cohort?  
What is the impact of using unstratified weights instead of stratified weights to estimate covariates coefficients in matched 
designs? 
What is the impact of using an appropriate method rather than a naïve statistical analysis when reusing nested case-control data?  
What is the impact of using selection dates of the controls when the censoring date in the nested case-control data set is ignored?  
Is there a practical advantage to using Kaplan-Meier or glm/gam weights? 
Studies III, IV 
Studies I, III, IV 
 
Study I 
Study I 
Studies I, III 
Estimating absolute risk  
Question 9 
Question 10 
Are the Langholz-Borgan and weighted methods suitable for estimating absolute risk from matched nested case-control data?  
Are the Langholz-Borgan and weighted methods comparable in terms of accuracy and efficiency?  
Study II 
Study II 
Overmatching  
Question 11 Does weighted partial likelihood help overcome overmatching? Study III 
Clustered data   
Question 12 What are the advantages of using a weighted Cox regression with clustered data? Study III 
Subgroup analyses  
Question 13 
Question 14 
Are subgroups analyses of nested case-control data valid when a subgroup is defined by a covariate measured at baseline? 
Is one method to be preferred among weighted Cox regression and conditional logistic regression for subgroup analyses of nested 
case-control data? 
Study IV 
Study IV 
  41 
7 RESULTS AND DISCUSSION 
In this thesis, both epidemiological and methodological/statistical questions were addressed, 
but the choice was made to focus on the latter type of questions. In addition, as summarised 
in Table 6.1, several questions were explored in different studies. The structure of Chapter 7 
will reflect these features.  
The results for all methodological/statistical questions are first considered where the same 
order as in Table 6.1 is followed. The epidemiological results (Studies I and III only) are 
presented in the last part of the chapter. 
7.1 Results regarding the methodological/statistical questions 
7.1.1 Reusing nested case-control data to address a research question 
regarding a new outcome 
For this theme (reusing nested case-control data) and context (answering a question regarding 
a new outcome), Study I gave the opportunity to answer several specific questions. Reusing 
nested case-control data which were sampled from an overlapping cohort to study another 
outcome, risk factors were investigated for contralateral breast cancer (our new outcome of 
interest).  
Table 7.1 presents the estimates obtained in several analyses. In the first column of the table 
are the results from our published article.114 This main analysis uses cases and controls from 
the reused data set as control data, together with the contralateral breast cancer cases; this 
combined data set is then analysed with a weighted Cox regression (i.e. weighted likelihood 
method). The weights are stratified on the matching factors used to sample the controls and 
calculated with a Kaplan-Meier analysis of the appropriate study base for the current study. 
The covariates which are included in the model are the four risk factors (multifocality of the 
breast cancer tumour, parity, histological type of the tumour and ‘family history’), in addition 
to the potential confounders (adjuvant treatment and age). All terms highlighted in bold style 
in the text above are features of the main analysis. All subsequent analyses involve a change 
regarding these features.  
The other columns of Table 7.1 present the results from analyses which were performed by 
making some variation of the first analysis. In the text which follows, the terms which are 
written in bold emphasise the feature under interest, i.e. the element which is modified 
compared to the first analysis. 
The estimates in column 2 were obtained when adding a covariate (the size of the breast 
cancer tumour). This variable could have indirectly influenced the sampling of the patients in 
the ‘Metastases study’ (and hence the current analysis) as this study included patients who 
had freshly frozen tumour material available for genetic analysis, which could be related to 
the size of the tumour. The analyses reported in all subsequent columns of Table 7.1 also 
included this covariate. The estimates in column 3 were obtained with weights which were 
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calculated from a Kaplan-Meier analysis of the study base relevant to the ‘Metastases 
study’ which included more patients than the study bas used in the main analysis. To obtain 
the estimates in column 4, only the sampled controls from the ‘Metastases study’ were 
reused to prepare the control data, instead of both metastases cases and controls. In column 5, 
the results are given where unstratified weights were used in the weighted Cox regression 
analysis, and in column 6, a naïve unweighted analysis was performed. Each of the columns 
3 to 6 will be compared with column 2, while the latter will be compared to the first column.  
7.1.1.1 Question 1  
What is the impact of the accuracy of the reconstruction of the underlying cohort from 
which the weights are calculated? (Study I) 
In parallel with the correct study base (relevant to the current study), the study base relevant 
to the ‘Metastases study’ was also reconstructed, and the weights with both study bases were 
computed. The study base relevant to the ‘Metastases study’ was not completely irrelevant to 
the current study, as most of the criteria to align the data sets were imposed by the 
‘Metastases study’. This latter study base was larger than the appropriate one as it included 
patients with several malignancies, representing around 13% of the patients. The estimates 
were, however, very similar, when using either study base to calculate the weights (Table 7.1, 
column 2 and 3). This can be expected when a large study base is used (both study bases 
were large), so that the risk sets were large at any event time and the impact on the weights is 
limited as shown in Figure 7.1. That could, however, be problematic for small study bases. 
 
 
 
 
 
 
 
 
 
Figure 7.1: Correlation between the stratified weights computed with the study base relevant to the 
current study and the study base relevant to the ‘Metastases study’. 
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Table 7.1: Adjusted risk estimates: hazard ratios and (95% confidence intervals) from weighted Cox regression analyses (five first columns) and unweighted Cox 
regression analysis (last column). 
Risk factors Main analysisa 
Additional 
covariateb 
Study base 
for metac 
Sampled controlsd 
Unstratified 
weightse 
Unweightedf 
Non-multifocal tumour (ref.) 1 1 1 1 1 1 
Multifocal tumour 
1.99 
(1.07, 3.70) 
1.94 
(1.03, 3.68) 
1.94 
(1.02, 3.69) 
1.97 
(1.03, 3.77) 
1.91 
(1.04, 3.51) 
1.56 
(1.03, 2.39) 
Nulliparous (reference) 1 1 1 1 1 1 
Parity 
0.40 
(0.18, 0.89) 
0.42 
(0.18, 0.95) 
0.41 
(0.18, 0.92) 
0.39 
(0.17, 0.91) 
0.50 
(0.24, 1.02) 
0.82 
(0.48, 1.39) 
Ductal histological type (ref.) 1 1 1 1 1 1 
Non-ductal histological type 
2.09 
(1.21, 3.59) 
2.11 
(1.20, 3.70) 
2.14 
(1.22, 3.77) 
2.14 
(1.21, 3.77) 
2.10 
(1.24, 3.55) 
1.79 
(1.23, 2.60) 
No family history (reference) 1 1 1 1 1 1 
Positive family history 
1.91 
(1.11, 3.28) 
2.04 
(1.17, 3.55) 
2.06 
(1.18, 3.59) 
2.06 
(1.18, 3.62) 
2.13 
(1.29, 3.54) 
1.59 
(1.11, 2.27) 
Chemotherapy (reference) 1 1 1 1 1 1 
Hormonal therapy 
0.71 
(0.39, 1.26) 
0.70 
(0.37, 1.31) 
0.64 
(0.34, 1.19) 
0.72 
(0.38, 1.37) 
2.81 
(1.55, 5.11) 
1.95 
(1.17, 3.26) 
Chemo + Hormonal therapy 
0.57 
(0.30, 1.07) 
0.59 
(0.30, 1.17) 
0.59 
(0.30, 1.17) 
0.60 
(0.30, 1.20) 
0.82 
(0.42, 1.62) 
0.77 
(0.43, 1.38) 
Age <45 (reference) 1 1 1 1 1 1 
Age 45-54 
1.23 
(0.62, 2.44) 
1.29 
(0.63, 2.64) 
1.22 
(0.60, 2.51) 
1.31 
(0.63, 2.69) 
2.07 
(1.063, 4.02) 
1.69 
(0.98, 2.93) 
Age >54 
0.96 
(0.49, 1.88) 
0.97 
(0.48, 1.96) 
0.95 
(0.47, 1.89) 
0.96 
(0.47, 1.93) 
1.09 
(0.55, 2.14) 
1.18 
(0.69, 2.03) 
Tumour size (mm) -- 
0.99 
(0.96, 1.02) 
0.99 
(0.96, 1.02) 
0.99 
(0.96, 1.02) 
0.99 
(0.96, 1.02) 
0.99 
(0.97, 1.02) 
a Results obtained from a weighted Cox analysis, adjusted for confounders, with weights computed by stratified Kaplan–Meier analysis of the relevant 
study base. 
b Same as the main analysis when adding the tumour size of the breast cancer as an additional covariate. 
c Same as the analysis in the 2nd column with weights computed with the imperfectly reconstructed study base, i.e. study base relevant to the ‘Metastases 
study’. 
d Same as the analysis in the 2nd column with the 398 sampled controls only instead of the whole ‘Metastases study’ case-control dataset  
e Same as the analysis in the 2nd column with unstratified weights.  
f Naïve unweighted analysis adjusted for assumed confounders. 
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Relating to the question of the study base reconstruction, there were also some concerns 
about the role of the tumour size in the sampling of the ‘Metastases study’. It was not 
possible to include this variable in the weights, because the sampling was not stratified on this 
variable, but the variable was included in the analysis to take into account the possible bias 
due to this variable (Table 7.1, column 2). In the published paper, this variable was removed 
as it did not have any impact on the results (Table 7.1, column 1).114  
7.1.1.2 Question 2  
Is there a difference in the estimates when reusing a whole nested case-control data 
set or when only the sampled controls of this data set are reused? (Study I) 
The results presented in table 7.1, in the second and fourth columns, show that the estimates 
were similar when reusing the 528 patients (148 metastasis cases and 380 controls of the 
‘Metastases study’) or when reusing only the 398 sampled controls of the ‘Metastases study’ 
among whom 18 patients developed a metastasis after being sampled (i.e. they became cases 
later during their follow up time).  
This is not surprising. The 398 patients, including the 18, were weighted, and with their 
weights, these patients were representative of the study base. In particular, the 18 were 
representative of the special subgroup of patients who developed metastases and became 
cases during their follow-ups (i.e. the 148 case patients in the ‘Metastases study’). Figure 7.2 
compares the actual number of individuals in this subgroup who remain in the nested case-
control data set over time and the corresponding number recovered with the weights when 
retaining only the patients who had been sampled as controls and who are weighted.  
 
 
 
 
 
 
 
 
 
Figure 7.2: Number of case patients in the ‘Metastases study’ over time and corresponding numbers 
recovered with the weights. 
 
  45 
For example, when the follow-up started, the actual number of patients in this subgroup was 
148 and this number is compared to the recovered number from the 18 weighted patients. At 
the start of the follow-up, this recovered number was 265, clearly overestimating the actual 
number. The figure shows how these two numbers (the actual and the recovered) evolve 
during the entire follow-up time. With the exception for the first year, the recovered and 
actual  numbers are quite close to each other. 
7.1.1.3 Question 3  
What is the impact of the choice of data which are reused to analyse the new outcome 
(when a choice is possible) on the final data set and for the interpretation of the 
estimates? (Study I) 
The answer to question 3 is based on the number of patients which could be included in our 
final analysis (see Figure 4.1). The consequence of the alignment procedure in Study I was 
that the data used for analysis was reduced drastically: from 853 contralateral breast cancer 
cases, only 106 remained eligible, mainly due to the restriction of the study period. The 
maximum follow-up time period of the ‘Metastases study’ was nine years while the 
contralateral breast cancer cases were followed up during 30 years from breast cancer 
diagnosis date. This significant difference in follow-up length was the main reason why the 
cases data set was reduced so dramatically. However, as the criteria for both studies had 
further differences, the number of patients retained in the analysis was further reduced. As 
another consequence, the interpretation of the analyses results is limited to the population 
represented by the study base relevant to the current study, i.e. restricted to the same common 
criteria. 
The main lesson which results from this observation is that, should there be the possibility to 
choose among several candidates for data sets to be reused, the best candidate will be 
characterised with larger criteria, if no other feature influences the choice.  
7.1.2 Breaking the matching and weighting individuals 
In general terms, breaking the matching and reusing data are similar. As in all studies, the 
matching was ignored, several questions were addressed in different studies and can be 
answered in a more general context than the context of the former section.  
7.1.2.1 Question 4  
How well does the weighting system reconstruct the cohort and each subgroup of the 
cohort? (Studies III and IV) 
Question 4 was addressed in detail in Study IV, and illustrated in Study III. We showed in 
Study IV that the Kaplan-Meir weighting system was able to reconstruct, on average, the 
correct number of individuals at risk over time. This was shown for the whole cohort, but also 
for all subgroups of the cohort. In cases of stratified sampling, the same results were obtained 
with stratified weights, while unstratified weights were not able to reconstruct the cohort 
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appropriately. This is shown in Figure 7.3 obtained in simulation studies. Figure 7.4 shows 
how this did apply in Study III.  
 
 
Figure 7.3: Ratio (with two standard deviations) of the numbers of individuals at risk over time 
recovered with stratified weights (left panel) and unstratified weights (right panel) from nested case-
control data that was matched on the confounder, to the actual numbers of individuals at risk in the 
cohort 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4: Ratio of the numbers of individuals at risk over time recovered with stratified weights in 
Study III, to the actual numbers of individuals at risk in the study base 
 
In Figure 7.4, the recovered numbers over-estimated the actual numbers of individuals during 
the first third of the follow-up time. Several hypotheses can help to understand the reason for 
this. 1) Caliper matching was performed on age with an interval around the case’s age of 5 
  47 
years, while to compute the weights ten-year fixed age categories were used. The choice of 
ten-year categories broadened the risk sets to sample in, lowering the sampling probabilities, 
and hence increasing the weights. 2) The sampling, which was stratified on decade of breast 
cancer diagnosis dates could have been performed in a somewhat more convenient way than 
was planned, and could have been tighter that described. For example, if patients with 
diagnosis dates closest to the case’s diagnosis date were more likely to be sampled; if this 
happened, it would have the same result as for the age variable above.  
More important though, is the question regarding the impact of a poor reconstruction of the 
cohort on the estimates in the analysis. As the variables which could have led to the 
inaccurate reconstruction (age and decade of breast cancer diagnosis) were included in the 
analysis, and in the weights, we do not think that a bias is to be expected. This will further be 
illustrated in addressing the question which follows. 
7.1.2.2 Question 5  
What is the impact of using unstratified weights instead of stratified weights to 
estimate covariates coefficients in matched designs? (Studies I, III and IV) 
In Studies I, III and IV, the findings of Støer et al. 97 were challenged, according to which, 
stratified and unstratified weights provide similar estimates for the exposure of interest. In the 
fifth column of Table 7.1 the results from the analysis with unstratified weights are presented. 
The estimates for the exposures are similar to the estimates with stratified weights, provided 
that the potential confounders which were matching variables were included in the weighted 
Cox model. The main advantage of using stratified weights, is that we expect recovering 
correct estimates for all variables, including the matching factors used in the ‘Metastases 
study’ (Table 7.1, column 2), while using unstratified weights led to incorrect coefficient 
estimates for these latter coefficients (Table 7.1, column 5). This was further illustrated in 
Study IV, where we showed that unstratified weights yielded a correct estimate of the main 
exposure but were not correctly estimating the matching factor, whereas, with stratified 
weights, coefficients for both exposure and matching factors were correctly estimated (Figure 
7.5). 
The accuracy of exposure estimates with unstratified weights was also apparent in the results 
provided in Study III. They are presented in Table 7.2 and discussed later in the text. 
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Figure 7.5: Estimates (± 1 standard error) for the exposure and the matching factor (confounder) 
obtained with the cohort analysed with Cox regression and the nested case control (NCC) data 
analysed with weighted Cox regression, using either stratified (strat.) or unstratified (unstrat.) weights. 
 
7.1.2.3 Question 6  
What is the impact of using an appropriate method rather than a naïve statistical 
analysis when reusing nested case-control data? (Study I) 
The sixth column of Table 7.1 provides an answer to this question. The estimates were biased 
when using a naïve unweighted analysis, compared to the weighted analysis in the second 
column of Table 7.1. It is difficult to judge in advance the extent of the bias for the main 
exposure(s), but serious bias in the matching factors could be expected. In this study, while 
the risk factor estimates were only slightly biased to the null, the estimates for age and 
adjuvant treatment (the matching factors in the prior study) were more seriously biased, as 
expected. 
7.1.2.4 Question 7  
What is the impact of using selection dates of the controls when the censoring date in 
the nested case-control data set is ignored? (Study I) 
Ignoring the last date of follow-up for the controls and using their selection date instead leads 
to important biases in the estimates, as the chosen date influences both the weight (through 
Equation 5.1 or 5.2) and the likelihood (through Equation 5.3) (data not shown). This 
highlights the care that has to be taken when collecting dates in nested case-control studies, 
should the collected data be intended for use in another study, or the IPW approach be used 
for the analysis. 
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7.1.2.5 Question 8  
Is there a practical advantage to using Kaplan-Meier or glm/gam weights?   
(Studies I and III) 
This question could be re-written as: Was it possible to choose the type of weights between 
Kaplan-Meier and glm/gam type of weights? Using the glm/gam type of weights was not 
possible with the anonymised data sets (Study I and III). Indeed, as the calculation of the 
glm/gam weights requires having a variable in the cohort data set indicating who was 
sampled for the nested case-control study, and as such indicators did not exist for ethical 
reasons, these weights could not be used. In order to highlight this statement, Figure 7.6 
(inspired from Figure 4.1) illustrates the difference between the two possible situations. On 
the left hand side of the graph is a situation where the available data is not anonymised, 
which allows considering the available data as part of the study base, and having access to a 
broader choice for the type of weights, the statistical analyses and the software programs. On 
the right hand side is the situation of the data in Study I, where the data had been anonymised 
so that we can no longer link the available data to the study base and the choices are 
restricted, for weights calculation, statistical analyses and software programs. 
A finding in this study was that the Kaplan-Meier weights are more flexible than the glm/gam 
weights as they can adapt to any situation. This advantage had never been mentioned before. 
Unfortunately, dealing with anonymised data hinders the (straightforward) use of the 
multipleNCC package developed in R, which means that the codes posted on 
http://www.meb.ki.se/~biostat/ are still useful.   
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Figure 7.6: Difference between data which are included in the study base (with an identifier) (left panel) and data which do not have such identifier due to 
anonymisation (right panel). The figure is inspired from Figure 4.1 which applied to Study I. 
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7.1.3 Estimating absolute risk with case-control data 
7.1.3.1 Questions 9 and 10  
Are the Langholz-Borgan and weighted methods suitable for estimating absolute risk 
from matched nested case-control data? (Study II) 
Are the Langholz-Borgan and weighted methods comparable in terms of accuracy and 
efficiency? (Study II) 
These two questions were addressed in Study II and the results are shown in Figure 7.7. The 
Langholz-Borgan and weighted approaches both yielded unbiased absolute risk estimates at 
various time points (up to 20 years in the simulation studies) in the three following settings: 
(a) no additional matching, (b) matching on one confounder (gender), and (c) matching on 
two confounders (gender and age-group). The standard error of the Langholz-Borgan method 
was slightly larger than the standard error of the weighted method when matching was 
involved. We can thus confirm that the nested case-control design is an alternative to the 
cohort design for absolute risk estimation, and that it is possible to accommodate the 
Langholz-Borgan method in a matched nested case-control study. In addition, we found that 
there was no advantage of any of the two approaches in term of precision in case of no 
matching. In cases of matching, the weighted method was more precise than the Langholz-
Borgan method.  
In cases of fine matching (d), the weighted method should be preferred but, depending on 
how fine the matching is and how small the initial cohort is, there could be some bias with 
this latter method as well. In the simulation studies, the Langholz-Borgan approach gave 
biased absolute risk estimates at various time points and larger standard errors (especially for 
long-term prediction), while the weighted approach provided unbiased absolute risk estimates 
unless the initial cohort was small (10,000 individuals).  
 
 
 
 
 
 
 
Figure 7.7: The average of absolute risk estimates for females across 500 realisations and their 95% 
confidence intervals in scenarios (a) no-matching and (d) fine matching. Cohort estimates  (solid 
lines), Langholz–Borgan (L-B) estimates (dashed lines) and weighted estimates (dotted lines). 
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In the real data application, the weighted method performed better than the Langholz-Borgan 
method which provided biased estimates of absolute risk for long term prediction. The reason 
for this is not fully understood.  
7.1.4 Overmatching 
7.1.4.1 Question 11  
Does weighted partial likelihood help overcome overmatching? (Study III) 
This question was tackled in Study III. The estimates obtained in the analyses of the 1051 
patients were similar in magnitude for both the conditional logistic regression and the 
weighted Cox regression, but the standard errors of the latter analysis were smaller (or equal) 
for all analyses (Table 7.2, two first columns). The overmatching was mitigated but the gain 
in power was quite modest by using weighted Cox regression instead of conditional logistic 
regression. As mentioned earlier, using stratified or unstratified weights led to similar 
estimates for the exposure coefficients (Table 7.2, columns 2 and 3). 
Table 7.2: Adjusted coefficients (log hazard ratio) with standard errors for developing lung cancer 
five years or more after breast cancer. The conditional logistic regression was performed with 1018 
patients in 509 matched sets and the weighted Cox regression is performed with 1051 unique patients.  
 
Risk factors Conditional logistic 
regression 
Weighted Cox regressiona 
Stratified weights                   Unstratified weights 
 Log hazard ratio (standar error) 
 Univariate 
No radiotherapy 1 1 1 
Radiotherapy 0.19 (0.16) 0.20 (0.16) 0.17 (0.15) 
No smoking 1 1 1 
Smoking 1.73 (0.19)  1.94 (0.16) 1.86 (0.16) 
   
 Multivariable  +  interaction 
No radiotherapy 
and no smoking 
1 1 1 
Radiotherapy -0.003 (0.29)  -0.26 (0.25)  -0.23 (0.24) 
Smoking 1.37 (0.32)  1.38 (0.29) 1.37 (0.28) 
interaction 0.54 (0.39)  0.78 (0.34)  0.68 (0.33) 
a 
all weighted analyses included adjustment for the matching variables used in the sampling i.e. age (continuous), 
region and decade of diagnosis. 
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7.1.5 Clustered data 
7.1.5.1 Question 12  
What are the advantages of using a weighted Cox regression with clustered data? 
(Study III) 
In study III, using a weighted Cox regression, we were able to use all the information which 
had been gathered for the two lungs in each patient, thereby doubling the number of data 
observations and increasing the power of the statistical analysis. The approach used showed 
how to best exploit data which were collected on cases and controls, treated and non-treated 
with radiation therapy and with all doses reconstruction carried out for both lungs. 
Some alternative to our approach exist. To use a conditional logistic regression analysis, 
while keeping the same outcome definition and retaining as much as data as possible, the data 
could have been been used as follows: the affected lung of a patient case is selected as case 
and analysed in sets with the ipsilateral lung of the control patient. This means that half of the 
data would be ignored, which would decrease the power as compared with our approach.  
Another possibility is the approach used by Prochazka et al.53 In their study, only women 
who were lung cancer cases treated with radiation therapy were selected, and the unaffected 
lung was considered as the control for the affected one. While this approach will avoid any 
problem of unmeasured confounding at the patient level and is definitely cost-efficient, it 
does not use the information from non-irradiated cases or control patients, and thus loses 
power. 
7.1.6 Subgroup analyses 
7.1.6.1 Questions 13 and 14 
Are subgroup analyses of nested case-control data valid when a subgroup is defined 
by a covariate measured at baseline? (Study IV) 
Is one method to be preferred among weighted Cox regression and conditional 
logistic regression for subgroup analyses of nested case-control data? (Study IV) 
The results of Study IV provided clear answers to these two questions. As shown in Figure 
7.8, both conditional logistic regression and weighted Cox regression provided on average an 
unbiased exposure estimate in subgroup analyses, disregarding the type of covariate used to 
define the subgroup (independent risk factor, matched or unmatched confounder, or effect 
modifier). The same conclusion applied in all tested simulation settings.  
However, the conditional logistic regression presented such a variability compared to the 
weighted Cox regression, that the latter should be preferred. This is not surprising because, in 
weighted Cox regression, all individuals belonging to a subgroup are participating in the 
analysis, while, for the conditional logistic regression, only sets which, by chance, include a 
case and a control belonging to the same subgroup are used in the analysis. The number of 
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sets which are lost will depend on the association between the outcome and the covariate and 
the prevalence of the various levels of the covariate as well as the prevalence of the exposure.  
 
 
Figure 7.8: Adjusted exposure coefficient with 95% confidence intervals (calculated with model 
based standard errors), provided by the analysis of the cohort (Cox regression), the nested case-control 
data (conditional logistic regression and weighted Cox regression), the eight cohort subgroups (Cox 
regression) and the eight subgroups of nested case-control data (conditional logistic regression and 
weighted Cox regression). 
 
7.2 Results regarding the epidemiological questions 
7.2.1 Study I 
The results regarding the epidemiological question of Study I (risk factors for contralateral 
breast cancer) are presented in the first column of Table 7.1. We found that the multifocality 
of the breast cancer tumour was a risk factor for contralateral breast cancer with a hazard ratio 
(95% confidence intervals) of 1.99 (1.07, 3.70). This is the first time that this factor is 
highlighted. This result is not surprising as multifocality has been shown to be associated 
with the lobular histological type of breast cancer, a known risk factor for contralateral breast 
cancer.82,83 
Parity was found to be protective against contralateral breast cancer (with a hazard ratio (95% 
confidence intervals) of 0.40 (0.18, 0.89)), which is in line with the literature where parity is 
often reported as a protective factor but usually with a non-statistically significant hazard 
ratio.73,80,81 
In addition, the main weighted Cox regression analysis confirmed that the known risk factors 
‘family history’ and ‘non-ductal histological type’ were associated with an increased risk of 
developing contralateral breast cancer with hazard ratios (95% confidence intervals) of 1.91 
(1.11, 3.28) and 2.09 (1.21, 3.59), respectively, in line with the literature.71,73-77 
In the analysis, cases of contralateral breast cancer whose breast cancer was diagnosed 
between 1992 and 1997 were included in order to reduce the drastic loss of available case 
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patients resulting from the study period alignment procedure (see Figure 4.1), or in other 
words to gain power. The same risk and protective factors were found when the time period 
for including contralateral breast cancer cases was 1992-2005 or 1997-2005, but the estimates 
were not statistically significant for the latter period. In our situation, there was no reason to 
suspect a problem by extending the study period to include contralateral breast cancer cases 
from 1992 (instead of 1997), as there were no major changes in this period for breast cancer 
diagnosis or treatment. This kind of choice is highly dependent on the clinical context and 
should be considered carefully. 
7.2.2 Study III 
In analysing how the risk of developing lung cancer after breast cancer is related to the dose 
of radiation therapy received for breast cancer treatment and the smoking habits of the 
patient, the following results were obtained. 
An interaction was found between the two carcinogens (radiation therapy and smoking), 
meaning that the hazard ratio of developing lung cancer increased (doubled) in smokers 
receiving radiotherapy compared to smokers who were not treated with radiotherapy. If this 
had already been mentioned,52,53,87 it is the first time that the interaction between smoking and 
breast cancer radiation therapy is characterised with a numerical value: the interaction 
coefficient was 0.78 (standard error = 0.34) leading to a hazard ratio of 2.19 (Table 7.2, 
second column). 
The analysis of the 2102 lungs was performed with weighted Cox regression, which can 
handle the clustered data in a simple way by using a robust variance. Both hazard ratio and 
absolute risk for a lung to develop cancer were estimated. The results show that the risk of 
developing lung cancer among smokers increased with increasing radiotherapy dose (P for 
trend = 0.026), with a hazard ratio of 8.63 (95% confidence interval: 5.04, 14.79) for smokers 
who received a radiation dose higher than 13 Gy compared to a hazard ratio of 4.09 for 
smokers who did not have radiotherapy. In contrast, no such relationship was found among 
non-smokers.  
The same observation applies when drawing the estimated curves of absolute cumulative risk 
for a lung cancer over the period from 5 to 25 years after breast cancer diagnosis (Figure 7.9) 
The main findings from the study are the interaction between the two carcinogenic factors 
and the trend of increasing risk with increasing radiation dose in smokers. However, the 
clinical relevance is limited by features of the data: the individual dose reconstruction 
procedure was subject to inaccuracies,53 the information on smoking was a simple binary 
variable,115,116 and the confidence intervals in the analysis were rather wide. In addition, the 
risk of lung cancer was likely overestimated because death was treated as a censoring event 
and not as a competing outcome.  
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Figure 7.9: The estimated absolute risk (i.e., probability) of cancer in a lung exposed to various 
radiation doses, estimated at various time points from 5 to 25 years after breast cancer for patients 
aged 54 years at breast cancer diagnosis, assuming no competing risk of death. 
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8 CONCLUSIONS AND PERSPECTIVES 
8.1 Achievements  
Using both real data sets and simulation studies, we challenged the weighted partial 
likelihood approach in analysing nested case-control data, in order to better identify its 
advantages and limitations. In doing so, the scope of this approach was both refined and 
extended.  
We showed that the weighting system using Kaplan-Meier weights enabled the 
reconstruction of the cohort, with, on average, the correct number of individuals at risk over 
time, both for the whole cohort, and in subgroups defined by a covariate measured at 
baseline. This result applied even for stratified design (i.e. when additional matching was 
performed on other covariates than time), provided that stratified weights were calculated. To 
our knowledge, this had never been shown before. This result suggests that any analysis or 
development made for cohort data could be applied to nested case-control data when using 
the IPW approach, but this would require confirmation studies. 
We showed also how this result applied with some limitations to real situations, which 
highlights the importance of recovering the exact sampling scheme of the available data as 
well as the correct identification of the study base from which the nested case-control 
sampling was performed. 
In case of stratified sampling, Støer et al. 97 already showed that unstratified or stratified 
weights provided similar exposure estimates if adjustments on the matching factors were 
made in the analysis. These results were confirmed in all the studies included in this thesis. In 
addition, when stratified weights were used, correct estimates for the matching factors were 
retrieved from the weighted partial likelihood, which is a further advantage of the IPW 
approach.  
Regarding absolute risk estimation, we showed that both the Langholz-Borgan and the 
weighted methods provided valid estimates in most situations, the latter showing slightly 
higher levels of precision than the former. In case of fine matching, the Langholz-Borgan 
method was more prone to be biased than the weighted method and had larger standard 
errors, so that our recommendation would be to give preference to the weighted method for 
calculating absolute risk. 
When overmatching is mentioned in the literature, it is often to try to prevent the issue from 
arising 54,57 and less frequently to explain how to mitigate the problem once it has arisen.58 
Using weighted partial likelihood to mitigate the problem of overmatching at the design stage 
is also part of the contribution of this thesis to the field, although results did only partially live 
up to the expectations. 
The importance of using appropriate methods compared to a naïve unweighted approach 
which leads to biased estimates was also highlighted, which was already pointed in case-
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control studies.33,34,54,117-119 We also demonstrated how the collected data on paired organs 
(i.e. clustered data) can be best exploited when using weighted partial likelihood. 
The subgroups analyses shed light on the validity of such analyses and on the advantages of 
weighted partial likelihood compared to conditional logistic regression for the precision of 
the exposure estimate. It is reassuring that these analyses are valid per se, but we agree with 
Pocock 67 that subgroup analyses should not be overused, a topic addressed in the literature 
about randomised clinical trial.65-69 Only subgroups defined by a covariate measured at 
baseline were investigated in our simulation studies, but extension to time-dependent 
covariates should not be an issue.120 
We finally addressed practical aspects related to the reuse of data. The consequences of 
reusing data which have narrow inclusion criteria, the restriction in the choice of type of 
weights which can be calculated when data sets are anonymised, and the importance of 
having information on censoring dates for controls were all pointed out. 
A major obstacle for using novel methods is the lack of software and guidelines. Study I 
provides such guidelines where all steps needed for data preparation and data analysis are 
explained in detail. Regarding software demand, an R package was developed and made 
available on CRAN,110,111 but, due to the features of our available data sets in Studies I and 
III, the multipleNCC package could not be used without some adaptation. The codes which 
we provided (at http://www.meb.ki.se/~biostat/), include weights calculations which are 
performed with unique codes, but also with the multipleNCC package. 
In this thesis, we focused on the IPW approach with Kaplan-Meier weights. The other 
likelihood methods, which were briefly exposed in Chapter 5 and which include a complete 
cohort likelihood approach,18,94 or a multiple imputation approach,95 would not be an option 
with the clinical data which was handled (Sudies I and III), as the nested case-control data set 
had been made independent from the study base. In such a situation the missing data and the 
available data cannot be linked which is a major obstacle for using these methods. The same 
obstacle prevented the use of glm/gam weights for the weighted partial likelihood approach 
as well as the straight utilisation of the multipleNCC package.  
8.2 Nested case-control design and other cohort sampling 
strategies 
In terms of study design, this thesis focused on the nested case-control design. The 
development of this design answered a need to optimise the efficiency of epidemiological 
research, but other designs answer the same need. Among the designs which sample within a 
well-defined cohort, the case-cohort design introduced in 1986 by Prentice 121 is another 
example of successful development. In the case-cohort design, the sampling is performed at 
baseline (inclusive sampling), where a subcohort is randomly sampled from the study base. 
This design and the nested case-control design (incidence density sampling) share aspects not 
only in terms of sampling,5-7 but also in terms of analysis. A similar form of weighted partial 
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likelihood is used for case-cohort data analysis, with the advantage of weights which are 
easier to calculate compared to the weights used in the weighted partial likelihood developed 
for the nested case-control design.2,17,122-126 Vandenbroucke and Pearce 6 presented a third 
way to sample within a cohort, i.e. exclusive sampling. This “extreme” case-control design 
has even been extended to ‘more extreme’ case-control design by Salim et al. 127 who 
developed a weighted partial likelihood approach for analysing the data, with weights which 
also use basic information from the underlying cohort.  
As the common feature of these three designs is the existence of a well-defined cohort, and as 
the weights used in the respective weighted partial likelihoods include basic information from 
the cohort, it gives the opportunity to highlight the value of having access to such cohorts in 
research. 
8.3 The value of population and health registers 
In Sweden, as well as in other countries, national/regional health and population registers are 
used for research purposes: cases for a specific outcome are selected and controls are 
subsequently sampled following a sampling procedure chosen by the research team and 
granted by the Ethical Review Board. The collection of detailed and often expensive data for 
the sample is then performed.  
The value of the registers for this selection and sampling role is well recognised, but there is 
an added value which is less known and which was highlighted in this thesis: the ability to 
use basic information from the register to perform non-traditional analyses. Indeed, the 
weighted method used in the thesis was relevant because we had access to basic information 
available in the well-defined underlying cohort and the applied sampling procedure was 
known. Lacking one of these aforementioned factors can hamper the use of the IPW method 
in nested case-control data analysis.  
On the other hand, while these factors are necessary, they are not sufficient. When analysing 
nested case-control data with conditional logistic regression, it is not necessary to collect any 
information on dates (event or censoring), as this information is useless for the analysis. The 
nested case-control data may thus lack information about dates, which could also hamper the 
use of the IPW approach. It is, therefore, equally crucial that the dates which are registered in 
the cohort are collected in the sample. While these should be easy to retrieve, this represents a 
change in some habits regarding data collection, and this could take some time before 
becoming the standard. 
8.4 Perspectives  
The achievements of this thesis are part of a bigger picture in epidemiology, which could be 
summarised with a key phrase: the need for flexibility. When data collection is expensive, 
there is a crucial need to optimise the cost-efficiency of research projects, which means both 
performing smart sampling and enabling the reuse of the expensive information which was 
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gathered. This is valid for clinical data retrieved from clinical charts, for example, but it is 
even more crucial for genomics with the expensive and large associated molecular data. 
Flexibility already characterises the development of various non-standard designs or 
sampling strategies which occasionally appear in the epidemiological literature. Their 
development is generally driven by a particular need, or a particular data situation. Such 
examples of needs and associated designs include: savings in time, cost or lowering 
computing burden (for example the “Exposure Enriched Case-Control” design 128), the 
targeting of informative individuals (for example, the counter-matching sampling of 
controls,129-131 and the end-point design 132), and designs and analyses which do not need 
access to the underlying cohort.133,134 This list is non-exhaustive. 
In this thesis, flexibility was present in combining data sets and in using weighted partial 
likelihood, as this method of analysis is much more flexible than the conditional logistic 
regression analysis. A possible extension of this work could be to explore how to extract 
more information from a prior nested case-control study. After the end of the original study, 
some of the controls will usually develop the disease. If information was available on when 
these controls developed the disease, it would be valuable to find out how to use this new 
information in order to update the estimates obtained in the prior study. 
One possible area of further development lies in exploring how to gain flexibility by 
combining designs into ‘hybrid’ designs. This kind of idea has already been explored with 
case-control studies.135,136 Given the similarities in the weighted likelihoods used in both 
nested case-control and case-cohort data analyses, possible hybrid designs could be created 
from these two designs. For example, when a subcohort is set up in order to address several 
research questions, it will likely be unnecessarily large to address a specific question. In this 
case, a nested case-control sampling within the case-cohort data could be superimposed, 
capturing a substantial part of the information available in the case-cohort data with a much 
reduced sample size. Another example could be, on the other hand, to augment case-cohort 
data with a nested case-control sampling when the subcohort does not include enough 
individuals (a situation which could happen when the subcohort has been followed up for a 
long time).  
Flexibility will always be needed when data have been collected following a given sampling 
procedure and are planned to be reused to address other research questions. We started a 
collaboration with a research team who had collected data following an extreme case-control 
design in order to answer an initial research question.137 They are now willing to address 
another research question using the same expensive data, but using a subgroup of the patients 
of the first study. In addition to this restriction, the new question involves a different starting 
time in the underlying cohort, and a different outcome and censoring definitions. Being able 
to exploit any information from the underlying cohort, as well as taking advantage of the 
similarities of the designs and of the variety of the potential statistical approaches is the key 
to overcoming design issues in such complex situations.    
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8.5 Concluding remarks 
This thesis has contributed to encourage researchers to use non-traditional approaches in 
analysing data. The wide applicability and potential advantages of the weighted partial 
likelihood approach for nested case-control data analysis has been further documented. We 
hope that this will eventually become standard practice.  
The thesis also contributed to building bridges between epidemiological research and 
statistical methods, as well as highlighting the close links between epidemiological study 
designs, which are too often artificially distinguished. 
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